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ABSTRACT: 
Faithful DNA replication and repair of DNA damage is important for prevention 
of disease and birth defects.  My thesis work utilized reverse and forward 
genetic approaches to identify novel genes involved in these processes.  In 
one set of studies, I investigated the function of MCM9, a protein specific to 
multicellular eukaryotes that is related to subunits of the DNA replicative 
helicase. Utilizing multiple mouse disruption alleles, I have shown MCM9 is 
dispensable for DNA replication, however it has a role in germ-line stem cell 
maintenance and/or proliferation.  Additionally, in the soma, Mcm9 mutation 
leads to increased cancer susceptibility, particularly hepatocellular carcinoma 
in males.  The phenotypes of MCM9 mutant mice and cells suggest that 
MCM9 evolved a specialized but nonessential role in DNA replication or 
replication-linked quality-control mechanisms.  In a second set of studies, I 
identified a hypomorphic allele of Fancm in a forward genetic screen for GIN 
mutations in mice. Fancm is a member of the Fanconi Anemia 
complementation group and facilitates repair of lesions at the DNA replication 
fork.  Similar to Mcm9, Fancm is required for producing a normal germ-line 
 stem cell pool and for tumor suppression in the soma.  Together, these genetic 
studies underscore the importance of accurate DNA replication and repair of 
replication-associated damage in mammalian reproduction and cancer. 
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Chapter 1: Introduction 
 
Efficient and accurate DNA replication is crucial to the health and survival 
of the species.  Defects in DNA replication can lead to mutations, insertions, 
deletions, chromosomal fragmentation, and whole chromosome amplifications or 
loss. Ongoing or elevated frequency of alteration of the genome leads to 
genomic instability (GIN), a hallmark of cancer.  To find new genes involved in 
GIN our lab conducted an ENU mutagenesis screen in mice.  This screen utilized 
micronuclei formation in peripheral blood as a biomarker to screen for potential 
GIN (1).  Micronuclei (MN) arise from acentric chromosome fragments or whole 
chromosomes that have not been incorporated in the main nuclei following cell 
division (2).  Since erythrocytes lack nuclei, and the expelling of the nuclei does 
not always include MN, flow cytometry was used to detect the change in 
micronuclei levels(1, 3).  From this screen we expected to find genes involved in 
DNA repair, DNA replication, and genes in DNA cell cycle checkpoints. Three 
mutations were pursued: Chaos1, Chaos3, and Chaos4 (Chromosomal 
aberrations occurring spontaneously).  Chaos1 contains a mutation in Polq and is 
involved in translesion synthesis repair of DNA, and is particularly important for 
somatic hypermutation (1, 4, 5).  Chaos3 contains a point mutation in a member 
of the DNA replicative helicase, Mcm4 (6). Chaos4 is an allele of Fancm, a 
member of the Fanconi Anemia complementation group which regulates DNA 
interstrand cross-link repair. Of these three alleles, Chaos3 and Chaos4 confer 
increased tumor susceptibility. 
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1.1 DNA Replication Initiation and Elongation 
 The Mcm gene family is composed of 8 genes, Mcm2,3,4,5,6,7, and in a 
subset of eukaryotes, Mcm8 and Mcm9.  These genes contain a highly 
conserved, ~200 amino acid “MCM domain” containing Walker A and Walker B 
motifs, an arginine finger, and a Zinc finger motif (Figure 1-1).  MCM2-7 form the 
replicative helicase (7–9) involved in both the initiation and the elongation of the 
DNA replication fork (10). The activities of these six proteins are highly controlled 
to prevent re-replication of DNA during a cell cycle (11).  Each of the MCM2-7 
proteins is essential.  Null mutations in Mcm2-7 are lethal in both yeast (12, 13) 
and mice (14).  Prior to the initiation and elongation of the replication fork the 
origin of replication needs to be “licensed” (Figure 1-2).  A licensed origin has all 
the factors needed for replication to begin.  First the origin is bound by the origin 
recognition complex (ORC) (Figure 1-2A).  This is followed by binding of CDC6 
and CDT1 which then proceeds to load on the MCM2-7 heterohexameric 
helicase (Figure 1-2B,C).  This collection of proteins consist the pre-replication 
complex (pre-RC) and the origin is now “licensed” (Figure 1-2D)(15).  In order to 
become active, CDC7 and CDK remove CDC6 and recruit MCM10 (Figure 1-2E).  
MCM10 with MCM2-7 recruits CDC45, followed by the rest of the replisome, the 
origin is now active (Figure 1-2F,G)(15).  
MCM2-7 are present at levels exceeding what is needed to execute their 
direct roles in replication initiation and elongation (Figure 1-2) (16–19).  Recent 
studies indicate that the primary reason for this excess is to license backup 
origins that are utilized to rescue defective origins.  These back-up origins can be  
3"
 
 
 
 
 
 
 
 
Figure 1-1: MCM gene family conserved motifs.  The highly conserved 200 
amino acid region seen in the MCM gene family is called the MCM domain.  This 
domain consists of a Walker A and B motif and an Arginine finger.  Outside of the 
MCM domain is a zinc finger. MCM8 and 9 contain a more classical form of the 
Walker A motif than seen in MCM2-7.  The Walker B motif canonical sequence is 
seen in MCM2-7 and MCM8, with the exception of Drosophila MCM8 that 
contains some conserved amino acid changes. MCM9 has some non-conserved 
amino acid changes in the Walker B motif (red) as well as some conserved 
changes (blue)."
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Figure 1-2: Replication licensing, initiation, and elongation 
A. ORC proteins bind to DNA replication origins.  B. CDT1 and CDC6 and load 
onto the pre-RC.  C.  MCM8 and MCM9 may be loaded onto the pre-RC based 
on their interaction with CDC6 and CDT1.  D.  The MCM2-7 heterohexameric 
helicase is loaded onto the pre-RC and now the origin or replication is licensed.  
E.  CDK and CDC7 replace CDC6 and recruit MCM10 to what will be the active 
origin.  F.  MCM10 recruits CDC45 which then brings in the replisome and 
replication is initiated, with G. elongation of the DNA replication fork at the active 
origin. 
5"
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activated under conditions of replication stress (20, 21).  Dysfunction of, or 
decreases in MCMs can cause genome instability and cancer (6, 14, 22–24).  
The Mcm4Chaos3 mutation causes mammary adenocarcinoma formation in >80% 
of females in approximately 1 year in the C3Heb/Fej (C3H) background (6).  In 
the C57BL/6J (B6) genetic background there is reduced survival and these 
animals are prone to histiocytic sarcomas (25, 26).  Another mutant in the 
MCM2-7 family, (Mcm2IRES-CreERT2/wild-type), causes a drastic decrease in MCM2 
levels.  These mice are prone to lymphomas and have stem/progenitor cell 
deficiency (23, 27). 
 
1.2 Divergent MCMs, MCM8 and MCM9. 
 Mcm2-7 genes exist in all eukaryotes.  However, there are two additional 
paralogs, Mcm8 and Mcm9, which are present only in a subset of eukaryotic 
species.  Both genes usually co-exist in genomes of that subset, except for 
Drosophila which has Mcm8 but lacks Mcm9 (Figure 1-3) (28, 29). Neither MCM8 
nor MCM9 have been shown to directly interact with the MCM2-7 helicase.  
Currently, there is no definitive role for MCM8 in DNA replication, but it is thought 
to be involved in the recruitment of CDC6 to replication origins (Figure 1-2C) 
(30).  MCM8 has helicase activity and may facilitate in the elongation of the 
replication fork (31).  Drosophila females lacking Mcm8 (Rec) have high levels of 
chromosomal non-disjunction and reduced fertility (28).  Rec is required for 
normal levels of meiotic crossing over, possibly by facilitating repair synthesis in  "
7"
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Figure 1-3: Phylogenetic tree of MCMs 
A-Phylogenetic tree of MCM2,3,4,5,6,7,8,9 in S.cerevisiae, D.melanogaster, 
X.tropicalis, M.musculus, and, H.sapiens.  Note that D.melanogaster only has an 
MCM8 that it is divergent from the other MCM8.  B-Phylogenetic tree of the 
MCM9 genes seen in a subset of higher eukaryotes. 
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these recombination intermediates.  The substantial divergence of Drosophila 
Mcm8 from orthologs in higher eukaryotes, as well as the absence of Mcm9 in 
the fruit fly, led Blanton et al. to hypothesize that Drosophila MCM8 may also 
provide MCM9 function (28). 
 Mouse Mcm9 was first described as encoding a 386 amino acid, C-terminal-
truncated paralog of the MCM2-7 proteins.  This truncated isoform (MCM9S) 
contains a partial MCM domain lacking the Walker B motif (32).  Upon further 
analysis, Lutzmann et al bioinformatically deduced that Mcm9 actually encoded a 
long isoform (MCM9L) that has both the Walker A and B motifs (33).  The 
predicted amino acid sequence of MCM9 reveals some unusual features.  The 
Walker A motif in MCM9 is more similar to the classical Walker A consensus than 
the MCM2-7 canonical sequence. The MCM9 Walker B motif is also atypical with 
some non-conserved amino acid changes (Figure 1-1). 
 From these studies information concerning the function of MCM9 is beginning 
to emerge.  It is upregulated in mid-to-late S-phase in NIH3T3 cells suggested a 
possible role in the termination of DNA replication (32).  It was subsequently 
reported that, in Xenopus, MCM9 interacts with CDT1 to load MCM2-7 onto 
replication origins.  Thus, MCM9 was thought to be required for pre-RC formation 
and DNA replication (33).  These studies showed that MCM9 is a positive 
regulator of CDT1 and a DNA replication co-licensor, counteracting the inhibitory 
effects of Geminin upon CDT1 (33).  Our own lab has found that MCM9 is not 
essential for DNA replication, but it does have roles in germ-line stem cells and 
tumor suppression (chapter 2 and (34)). 
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1.3 Germline stem cells 
Proper specification and maintenance of the germ-line stem cell is a key to 
maintaining the genome and vitality of the species, making germ cells the 
ultimate stem cell.  Germ cell development starts with the initial cell specification 
and cell proliferation of the primordial population in the extra-embryonic tissue 
(Figure 1-4A) at approximately embroyonic day 7.5 (E7.5). These germ cells then 
migrate towards the primitive gonads while still proliferating. Between E7.5 and 
E11.5 the primordial germ cells undergo epigenetic reprogramming that changes 
methylcytosine into and unmethylated cytosine, which causes ssDNA to form and 
the repair is facilitated through the base excision repair pathway (BER) (35).  
Once the germ cells arrive at the bipotential gonads the cells will continue to 
proliferate until they undergo sexual differentiation. This cell proliferation happens 
rapidly, expanding the number of germ cells from~100 to >20,000 cells (36, 37) 
(Figure 1-4A).  By E13.5 the male germ cells are arrested in mitosis and after 
birth will once again start to divide and populate the seminiferous tubules.  
Spermatogenesis begins in a coordinated wave for the first round of meiosis and 
the spermatogonial stem cells maintain the germ cell population in the male for 
life (Figure 1-4B).  The female germ cells enter meiosis I and arrest at diplotene 
until the oocyte is ready to be ovulated (37).  During gamete formation genome 
maintenance it is critical to prevent mutation, insertions, and deletions to prevent 
the offspring from inheriting detrimental diseases. 
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Figure 1-4 Germ cell formation and spermatogenesis"
A.  Germ cell formation in the embryo starts at embryonic day 7.5 (E7.5) and the 
initial population of germ cells is complete by E13.5. B.  Spermatogenesis starts 
with the spermatogonial stem cell which either self-renews or differentiates into a 
spermatogonia.  A number of cell divisions occur before meiosis.  Then the 
spermatocyte goes through1 final round of replication with 2 round of division to 
complete meiosis and is now a spermatid. 
A 
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1.4 Fanconi Anemia  
Fanconi Anemia (FA) is a rare human genetic disorder characterized by 
bone marrow failure, developmental abnormalities, decreased fertility, and high 
incidence of malignancies.  Cells from these patients have a high susceptibility to 
DNA crosslinking agents (38). DNA interstrand crosslinks (ICLs) are lesions that  
link two DNA strands and are cytotoxic since they interfere with both DNA 
replication and gene transcription. The Fanconi Anemia complementation group 
currently consists of 15 genes.  The complementation group can be sub-divided 
into 3 components, the core complex, the ID group, and the repair group.  The 
core complex consists of FANC-A,B,C,E,F,G,L, and M (Figure 1-5)(39, 40). The 
core complex is loaded to the site of damage partially by FANCM (41).  Then the 
core complex acts as an E3 ubiquitin ligase with the E2 protein UBE2T to mono-
ubiquitinate the ID heterodimer that consists of FANCD2 and FANCI (Figure 1-5) 
(42, 43).  This activation of the FA pathway is done in conjunction with activation 
of the ATR pathway that phosphorylates a number of the FA proteins (44–46).  
FANCM has a role in stabilizing ATR through its interaction with HCLK, and it 
also participates in RPA localization to sites of ssDNA (47–51). The repair group 
is activated by the ID group.  The repair group consists of BRCA2/FANCD1, 
FANCN, FANCJ, FANCO (RAD51C) and FANCP (SLX4). These proteins have 
roles in homologous recombination and translesion synthesis (Figure 1-5)(49–
52). The overall role of the Fanconi Anemia complex is to preserve genome 
stability.  This is accomplished through processing blocked and/or broken  
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Figure 1-5  The Fanconi Anemia complementation group 
FANCM is chromatin bound and acts as a sensor of DNA damage (red line seen 
in front of the DNA replication fork).  FANCM then anchors the rest of the FA core 
complex (in purple) to the site of damage.  The core complex acts as a E3 ligase 
and ubiquitinate FANCD2 and FANCI (dark blue).  This then allows the repair 
factors (red) to perform homologous recombination or translesion bypass of the 
damage. 
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replication forks through the coordination of homologous recombination and 
translesion synthesis (52).  
There are several knock-out (KO) mouse models of the Fanconi Anemia 
complementation group. They all have similar phenotypes including germ cell 
depletion and sensitivity to MMC, however only a subset have congenital defects 
and only one (FANCP/SLX4) recapitulates hematopoietic defects that are 
characteristic of the human disease (52).  Fancd2 and Fancm mouse mutants 
are the only ones that have been shown to have a higher incidence of cancer 
(53, 54). Fancm is unique from other FA mutants in that intercrosses of Fancm-/- 
animals yield a non-Mendelian ratio of female offspring.  The Fancm-/- 
homozygous cells exhibit a high incidence of sister-chromatin exchange (SCE), 
and have a decreased ability to mono-ubiquitinate FANCD2 (55).  Fancm is 
conserved through evolution and has homologues in yeast and archaea. 
Furthermore, unlike other FA gene mutations, Fancm cell lines also have 
sensitivity to UV (activates nucleotide excision repair) and camptothecin (CPT, 
activates double stranded break repair) (44), suggesting a role in other DNA 
repair pathways.  All these activities suggest FANCM is functions in a closely 
linked DNA replication repair pathway. 
 
1.5 Hypothesis 
Both MCMs and FA have roles at the DNA replication fork.  If the MCM2-7 
helicase is disrupted, activation of S-phase checkpoint occurs.  This allows for 
three main responses: stabilization of already perturbed replication forks, 
14"
inhibition of late origin firing, and co-ordination of cell cycle progression with 
repair events (56).  Both the MCM9 mutant and mutants in FA have germ cell 
loss, so is it possible that germ cells are very sensitive to specific perturbations of 
DNA replication?  Recently it has been suggested that FANCM is involved in not 
only sensing DNA damage, but also deciding which DNA repair pathway to 
choose.  The signal cascade from disrupted MCM2-7 helicase progression to 
activation of DNA repair and recovery from cell-cycle arrest is still not clearly 
understood.  My hypothesis is that MCM9 and FANCM both function at the DNA 
replication fork in a pathway that directly links perturbed DNA replication with 
DNA repair.  In the following chapters I hope to elucidate further the potential 
mechanisms from disrupted DNA replication to the potential sensors, to how the 
repair pathway may be chosen. 
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2.1 Abstract 
 
 Effective DNA replication is critical to the health and reproductive success of 
organisms. The six MCM2-7 proteins, which form the replicative helicase, are 
essential for high fidelity replication of the genome.  Many eukaryotes have a 
divergent paralog, MCM9, which was reported to be essential for loading MCM2-
7 onto replication origins in the Xenopus oocyte extract system.  To address the 
in vivo role of mammalian MCM9, we created and analyzed the phenotypes of 
mice with various mutations in Mcm9 and an intronic DNA replication-related 
gene Asf1a.  Ablation of Mcm9 was compatible with cell proliferation and mouse 
viability, showing that it is nonessential for MCM2-7 loading or DNA replication.  
Mcm9 mutants underwent p53-independent embryonic germ cell depletion in 
both sexes, with males also exhibiting defective spermatogonial stem cell 
renewal.  MCM9-deficient cells had elevated genomic instability and defective 
cell cycle re-entry following replication stress, and mutant animals were prone to 
gender-specific cancers, most notably hepatocellular carcinoma in males.  The 
phenotypes of mutant mice and cells suggest that MCM9 evolved a specialized 
but non-essential role in DNA replication or replication-linked quality control 
mechanisms that are especially important for germ-line stem cells, also for tumor 
suppression and genome maintenance in the soma. 
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2.2 Introduction 
 
 The eukaryotic Mcm gene family consists of 8 genes, Mcm2-7, and in a 
subset of organisms, Mcm8 and Mcm9.  They encode a highly conserved, ~200 
amino acid “MCM domain” containing Walker A and Walker B AAA+ ATPase 
motifs.  MCM2-7 forms the DNA replicative helicase (1-3).  The activities of 
MCM2-7 are controlled to prevent re-replication during a cell cycle (4).  In both 
yeast and mice, each of the MCM2-7 proteins are essential despite having 
structural similarity (5, 6).  Dysfunction of, or decreases in MCMs can cause 
genome instability and cancer (6-8). 
 Mcm8 and Mcm9 are both present in diverse eukaryotes, although yeast 
lacks them and Drosophila melanogaster has only Mcm8 (9, 10).  Drosophila 
Mcm8 is involved in meiotic recombination (9), while human MCM8 was 
suggested to enable recruitment of CDC6 to replication origins (11).  CDC6 is 
needed for loading MCM2-7 onto replication origins, and formation of the pre-
replication complex (pre-RC). 
 Mouse Mcm9 was first described as encoding a 386 amino acid, C-terminal-
truncated paralog of the MCM2-7 proteins (12).  This isoform (MCM9S) contains 
a partial MCM domain (see Figure 2-1) containing the Walker A-type ATPase 
motif, but not a Walker B domain.  A larger form (MCM9L) was predicted to 
contain both the Walker A and B motifs required for helicase activity in MCM2-7 
(13).  However, the canonical Walker A motif in MCMs is GDP[G/S]x[S/A]KS, 
while in MCM8 and 9 it is GDPG[L/T]GKS.  The latter is more similar to the  
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Figure 2-1. Mcm9 locus structure and isoforms.  (A) Mcm9 has 2 isoforms: 
Mcm9s and Mcm9L.  The former utilizes an alternative splice site in exon 7 that 
results in termination.  Triangles depict the insertion sites of the gene traps.  
XE518 created a deletion that includes Asf1a.  Locations of polymorphic SNPs 
used for measuring deletion size in the Mcm9XE518 allele are indicated.  From left 
to right, these are: rs51772485, rs46087546, rs51382030, rs51176035, 
rs47659858, rs49316622.  The Asf1a gene trap is located 640 bp downstream of 
exon 2.  (B) MCM9 isoforms and the gene trap alleles.  MCM9 contains a zinc 
finger, CDK site, and the MCM domain.  (C) Tissue expression of Mcm9 and 
Asf1a by semi-qRT-PCR.  Primer pairs used in the top 4 panels are sets 1-4, 
respectively, as shown in (A).  (D) qRT-PCR analysis of Mcm9 and Asf1a in 
mutant MEFs (n=3).  AWO = Mcm9AWO655; XG = Mcm9XG743. Error bars indicate 
Std Dev. 
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canonical AAA+ ATPase consensus of GxxGxGK[S/T].  The MCM9 Walker B 
motif is also atypical (CCIDEFNSL compared to the more canonical motif of 
MCM2-7 [C/V][C/L]IDEFDKM). 
 The first major functional study of MCM9 reported that in Xenopus egg 
extracts, MCM9 interacts with CDT1 to load MCM2-7 onto replication origins, and 
also counteracts the inhibitory effects of Geminin upon CDT1 for replication 
licensing (14).  Thus, MCM9 was deemed essential for pre-RC formation and 
DNA replication.  Here, we report that Mcm9 is not required for pre-RC formation 
or DNA replication in mice, but is important for germ-line stem cell maintenance 
and/or proliferation, genome stability, and cancer prevention. 
 
2.3 Results 
 
Structure of the Mcm9 locus 
 Based on available EST and genomic sequence data, Yoshida (12) 
characterized mouse Mcm9 as encoding a protein of 386 amino acids, whereas 
Lutzmann et al (13) presented bioinformatic evidence for a much longer 14 exon 
model encoding 1291 amino acids.  The latter is essentially identical to the 
current RefSeq gene model NM_027830. 
 To corroborate these gene models, we performed RT-PCR analyses of Mcm9 
and re-examined existing mRNA and EST data.  The shorter gene model, which 
is apparently synonymous with the 7 exon UCSC gene model uc007fbs.1 (Figure 
2-2), specifies an ORF beginning within its exon 2 to encode an N terminus that 
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Figure 2-2. The mouse Mcm9 locus and gene models.  Shown is a screen 
shot from the UCSC genome browser, July 2007 assembly. Two Mcm9 gene 
models are shown, and are transcribed right to left as indicated.  The uc007fbs.1 
UCSC gene model is shorter than the RefSeq NP_027830 model, due to usage 
of a splice donor site internal to exon 7 that bypasses a termination codon.  
There is no evidence supporting the 5'-most exon in the RefSeq model, marked 
by a red asterisk, and despite the RefSeq prediction that the entirety of this and 
the next exon is protein-coding, there is no evidence of strong sequence 
conservation (as shown by the "30-way Multiz alignment and conservation" track 
graphed at the bottom of the figure) as there is for other protein coding exons 
throughout the gene.  Furthermore, we were unable to verify an mRNA transcript 
containing this exon by RT-PCR. Therefore, we believe the correct gene 
structure has only 13 exons as indicated, and the initiation codon is within the 
indicated exon 2.  Note that our predicted exon 1, which we assume does not 
encode protein, is also not conserved.  The entirety of Asf1a lies within intron 7 
and is transcribed in the direction opposite to that of Mcm9. 
  Mcm9 uc007fbs.1
Asf1a
Mcm9 RefSeq NP_027830
ATG
13    12 11           10 9                                       8  7    6      5          4      3      2          1            
Exons
*
Human Mcm9 NM_017696.2 
Human Mcm9 NM_153255.4 
Human Asf1a NM_014034.2
Xenopus Mcm9 NM_001091304.1 
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coincides with other vertebrate orthologs (Figure 2-2).  The longer model predicts 
an additional 5’ exon that begins with an initiation codon, resulting in a 150 aa N-
terminal extension in the mouse protein compared to humans and other 
vertebrates (13).  However, there is no experimental or EST evidence to support 
this additional 5’ exon, and it is not evolutionarily conserved (Figure 2-2).  
Analysis of the 5’ region of Mcm9 with the First Exon Finder program concurred 
with the 5’ end specified in uc007fbs.1.  Finally, whereas we failed to generate 
RT-PCR products using a primer situated in the predicted exon 1 of NM_027830, 
amplimers were produced when the 5’ primer was situated in exon 1 of 
uc007fbs.1 (Figure 2-2).  Therefore, we conclude that the 5’ structure of mouse 
Mcm9 is as depicted in Figure 2-1A, in agreement with uc007fbs.1 and as 
originally reported (12). 
 Existing DNA sequence data supports the existence of two alternative C-
terminal Mcm9 mRNA isoforms, corresponding to those previously described 
(12,13).  As depicted in Figure 2-1, the different isoforms appear to be generated 
by alternative usage of a splice site within exon 7.  Failure to utilize this site 
results in the shorter isoform (Mcm9S), whereas splicing to exon 8 creates the 
longer isoform (Mcm9L).  The existence of Mcm9S transcripts (equivalent to 
UCSC gene model uc007fbs.1) is supported by at least 3 ESTs (AK046636, 
AK018494, BB648447), and RT-PCR.  Numerous ESTs validate the 3’ structure 
of RefSeq NP_082106 (which we designate Mcm9L).  Mcm9L contains 13 exons, 
is 4836 bp in length, and encodes an 1134 aa protein (Figure 2-1A). 
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Genomic structure of the mouse Mcm9 locus and mRNA isoforms.  
Although RefSeq and published Mcm9 gene models are available (12, 13), we 
performed additional bioinformatic analyses and targeted RT-PCR to derive the 
correct structure as shown in Figure 2-1.  Mcm9 produces two alternative C-
terminal mRNA isoforms by alternative usage of a splice site within exon 7.  
Skipping this site results in a short isoform (Mcm9S) encoding a protein of 386 
amino acids. Splicing to exon 8 creates a longer isoform (Mcm9L) encoding an 
1134 amino acid (aa) protein (Figure 2-1A).  MCM9s contains only half of the 
conserved MCM domain containing the Walker A motif (Figure 2-1B). 
 The 7th intron contains another gene, Asf1a (Anti-silencing function 1 homolog 
A) with a transcriptional orientation antisense to Mcm9 (Figure 2-1A).  ASF1a is a 
histone chaperone with diverse functions, including the regulation of replication 
fork progression under normal and replication stressed conditions (15, 16).  
Evidence suggests it does so by interacting with MCM2-7 via a histone H3-H4 
bridge to transfer histones from dissociated nucleosomes to newly forming 
nucleosomes in the wake of the replication fork (15). 
 
Mcm9 isoforms are expressed ubiquitously in mice.   
 EST data in Unigene show that Mcm9 is expressed in many tissues, but does 
not distinguish between the 2 isoforms.  RT-PCR analysis of Mcm9S and Mcm9L 
revealed expression of both in all tissues and through early development (Figure 
2-1C).  Levels of transcription in the gene body were assessed by analyzing 
GRO-Seq (Global Run-on Sequencing) data from ES cells and mouse embryonic 
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fibroblasts (MEFs) (17).  This method determines the amount and locations of 
engaged RNA polymerase on a gene at the time of the assay (18).  Run-on 
transcripts are produced across the entire Mcm9 gene body.  The expression 
levels of mature transcripts indicate that the amounts of each isoform produced 
are similar, based on the exon sequence counts of Mcm9S and Mcm9L (19) 
(Figure 2-3).  Asf1a had similar amounts of engaged RNA pol II (Figure 2-3). 
 
MCM9 is not required for DNA replication.   
 To determine the in vivo function of the MCM9 isoforms, we generated mice 
containing 3 different gene trap insertions within Mcm9 (Figure 2-1A,B).  We also 
generated a mutant allele of Asf1a (Asf1aALO673) to explore potential regulatory or 
functional relationships between the two genes. 
 The Mcm9XE518 insertion actually caused a deletion beginning downstream of 
Mcm9 exon 4, extending through the entire Asf1a gene, and terminating 
upstream of the final Mcm9 exon (Figure 2-1A).  Thus, Mcm9XE518 is null for 
Asf1a and presumably Mcm9.  Intercrosses of Mcm9XE518/+ mice failed to produce 
newborn homozygotes (P<<0.001 by Chi2; Table 2-1), indicating the allele is 
embryonically lethal.  Timed matings revealed that Mcm9XE518/XE518 embryos were 
viable at E9.5 but were smaller and developmentally arrested at a stage 
resembling E8.5 embryos (Figure 2-4B).  These embryos contained no 
detectable Asf1a mRNA or Mcm9 transcripts downstream of the gene trap 
insertion site (Figure 2-4E). 
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Figure 2-3. The ES and MEF GRO-seq maps of Mcm9 and Asf1 loci 
compared with RNA-seq maps of ES cells and embryoid bodies.  GRO-seq 
and RNA-seq maps are presented in a strand-specific manner, with transcripts 
along the top/forward (red +) and bottom/reverse (blue -) strands. Mappable 
regions are depicted as black bars in the top row, and RefSeq gene annotations 
are shown in the bottom row. Y-axes show the total sequence reads per 1 kb per 
one million of total uniquely mapped sequences. Note that RNA Pol II occupancy 
peaks downstream of the annotated UTRs; this is typical since the polymerase 
proceeds past the polyA site before stopping (see Core et al, Science 2008, 
322:1845). 
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     Because Asf1a is also disrupted in the Mcm9XE518 allele, the lethal phenotype 
could be due to mutation of either gene or a combination of both.  To distinguish 
between these possibilities, we created mice bearing the Asf1aALO673 gene-trap 
allele, which is predicted to truncate 129 C-terminal amino acids from the 209 aa 
protein. Homozygotes died at midgestation, with a phenotype similar to 
Mcm9XE518/XE518 embryos (Figure 2-4D).  The phenotype is likely due to loss of 
Asf1a alone, since normal Mcm9 transcripts are produced in cis from the 
Asf1aALO673 allele (Figure 2-4F).  As expected, Mcm9XE518 failed to complement 
the lethality of Asf1aALO673 (Figure 2-4C, Table 2-1).  These data demonstrate 
that neither gene is required for cell division (and presumably DNA replication) 
during the first half of mouse gestation, a period of dramatic cell proliferation.  
However, these data do not reveal the developmental role of MCM9, since the 
lethal phenotype of Asf1a in the Mcm9XE518 allele obscures or precludes potential 
contemporaneous or subsequent roles. 
 Since ASF1 physically associates with MCM2-7 and facilitates nucleosome 
re-assembly during DNA replication and DNA repair (15, 20), processes that may 
overlap with MCM9, the question arises as to whether the physical arrangement 
of these two genes (which is conserved in mammals and chickens but apparently 
not zebrafish, based on current genome assemblies) is entirely coincidental. It is 
possible that there is a regulatory relationship between the genes, either with 
respect to their sharing common enhancer elements or modulators of chromatin 
structure, or in still more complex ways involving the complementarity of their 
transcripts or the interplay of the mechanics of divergent transcription complexes. 
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Table 2-1 Viability of gene trap alleles      
          
Mcm9XE518 
Intercross    
Asf1aALO673 
Intercross    
 XE/XE XE/+ WT   AL/AL AL/+ WT  
Observed 0 58 40  Observed 0 27 16  
Expected 24.5 49 24.5  Expected 10.75 21.5 10.75  
χ2 P = 
1.55E-
08    χ2  P = 
6.36E
-04    
          
          
  Mcm9XE518 X Asf1aALO673     
   XE/AL AL/+ XE/+ WT    
  Observed 1* 16 23 15    
  Expected 13.75 13.75 13.75 13.75    
  χ2  P = 
3.42E-
04 * born dead     
          
Mcm9XG743 
Intercross    
Mcm9XE518 X 
Mcm9XG743    
 XG/XG XG/+ WT   XE/XG 
XE/
+ XG/+ WT 
Observed 62 123 63  
Observ
ed 11 9 14 16 
Expected 62 124 62  
Expect
ed 11.25 
11.
25 11.25 11.25 
χ2 P = 0.99    χ2 P = 0.37    
          
Mcm9AWO655 
Intercross    Mcm9
XE518 X Mcm9AWO655   
 AW/AW AW/+ WT   XE/AW XE/+ AW/+ WT 
Observed 12 33 11  
Observ
ed 3 3 6 6 
Expected 14 28 14  
Expect
ed 4.5 4.5 4.5 4.5 
χ2 P = 0.40    χ2 P = 0.57    
 
Legend: Observed and Expected values are for liveborn pups of the indicated 
genotypes. Red c2 P values indicate a significant loss of one or more genotypic class in 
any given cross. XE=Mcm9XE518, XG=Mcm9XG743, AW=Mcm9AWO655, AL=Asf1aALO673. 
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Figure 2-4. Midgestation lethality in MCM9- and ASF1A-deficient embryos.  
(A-D) embryonic day 9.5 embryos. (E) RT-PCR of e9.5 embryos.  Primers for 
Mcm9S and Mcm9L are sets 2 and 3, respectively, from Fig. 1A. Primers 
(XE518WTF & XE518GTR) for Mcm9XE are specific for the gene trap fusion 
transcript. (F) RT-PCR/sequencing of polymorphic coding SNPs (rs51382030 for 
Asf1a; rs51772485 for Mcm9). The WT allele here is C3H, which is identical to 
the parental 129-based gene trap chromosome.  XE = Mcm9XE518 ; AL= 
Asf1aAL0673.  Bars = 500µM. 
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However, transcription of Mcm9 through the Asf1a gene is not required for Asf1a 
transcription in cis (Figure 2-1D), and intact Asf1a is not needed for Mcm9 
transcription (Figure 2-4F).  These results indicate that if there is indeed a 
regulatory relationship between the genes, it is likely to be related to sharing 
control sequences, identical regional chromosomal structure, or post-
transcriptional processing. 
 
Mice with severe depletion or elimination of Mcm9 are viable.   
 To identify the in vivo roles of each Mcm9 isoform, two other gene-trap alleles 
were utilized that do not ablate Asf1a.  Mcm9XG743 is located downstream of exon 
7 and Asf1a mRNA levels are ~75% of WT (Figure 2-1D).  Mcm9XG743 is 
predicted to allow production of the entire MCM9S polypeptide, either as a fusion 
to β-geo or as the endogenous protein (Figure 2-1B).  A slight amount (<3%) of 
mRNA was detected that corresponds to splicing over the gene trap (exon 7-8 
products). Mcm9S and/or fusion transcripts were also reduced from WT levels 
(Figure 2-1D).  These results indicate that Mcm9XG743 is severely hypomorphic or 
null for Mcm9L, and potentially hypomorphic for Mcm9S.  Heterozygote 
intercrosses produced Mcm9XG743/XG743 offspring at the expected Mendelian ratio 
(P=0.98; Supplemental Table 2-1).  The Mcm9AW0655 allele, which effectively 
terminates transcripts upstream of the entire MCM domain (Figure 2-1A,B,D), 
thus appears null for Mcm9 but leaves Asf1a transcription intact (Figure 2-1D).  
Mcm9AWO655/AWO655 and Mcm9AWO655/XE518 animals are completely viable (Table 2-
1).  Therefore, MCM9 is unnecessary for DNA replication. 
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MCM9 deficiency causes germ cell loss.   
 Despite being grossly normal, Mcm9XG743 male homozygotes had markedly 
smaller testes than WT littermates, a differential that was evident at puberty and 
widened over time (Figure 2-5A).  Despite a consequent 67% decrease in 
epididymal sperm concentration at 12 weeks of age, these mutant males were 
fertile.  Testis histology revealed three notable seminiferous tubules 
abnormalities (Figure 2-5B-D).  The most striking was progressive germ cell 
depletion.  The second was the presence of seminiferous tubule sections (~5%) 
lacking spermatogonia (the adult germ-line stem cells), but containing 
differentiated meiotic spermatocytes and/or postmeiotic spermatids (Figure 2-5D, 
arrows).  The third class of abnormal tubule cross sections (5%) contained a 
cohort of spermatocytes arrested in meiosis (Figure 2-5D, inset).  These 
abnormalities were also observed in Mcm9AWO655 male homozygotes and 
compound heterozygotes (Figure 2-6).  Notably, mice with severe depletion of 
MCM2-7 are fertile and do not exhibit these germ cell loss phenotypes (Figure 2-
6) (6, 8), suggesting that the germ cell effects in Mcm9 mutants likely occur by 
mechanisms distinct from MCM2-7 helicase defects. 
Young Mcm9XG743/XG743 females were fertile but also exhibited germ cell loss. 
Mutant 6-12 wk ovaries had fewer total follicles, and were nearly devoid of 
primordial follicles.  Oocytes were almost completely absent at 24 weeks (Figure 
2-5E,F).  Most Mcm9AWO655/AWO655 females were infertile and exhibited ovarian 
hyperplasias and tubulostromal adenomas consistent with premature ovarian 
failure (see below). 
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Figure 2-5. Mcm9 mutations cause germ cell depletion and loss of 
spermatogonial stem cells. (A,B) quantification of testis weights and 
histological abnormalities. * significantly different from WT, ** significant 
decrease in mutant testis size over time (n=10). Abbreviations in (B) for 
seminiferous tubule cross-sections that contain or exhibit the following: 
GMC=Giant multinucleated cells; MEI=Meiotic arrest; MW=missing wave of 
spermatogenesis; GCD=Germ cell depletion; Norm= normal. (C,D) H&E-stained 
histological sections of testes from 12 wk old mice of the indicated genotypes. 
WT= wild type; XG = Mcm9XG743 (200X). Error bars indicate Std Dev.  
Seminiferous tubules marked with “*” are devoid of germ cells; those marked with 
“^” exhibit meiotic arrest (inset); and those indicated by arrows are depleted of 
spermatogonia but undergoing a final wave of spermatogenesis.  Circled tubules 
are examples of normal spermatogenesis. (E,F) H&E-stained histological 
sections of ovaries from 24 wk old mice of the indicated genotypes. (G-L) 
Immunofluorescence of 1 dpp testes (G,H) and ovaries (200X) (J,K) of the 
indicated genotypes.  MVH (green) stains germ cells and DAPI stains nuclei 
(blue). (I,L) Germ cell counts from MVH staining data at 1dpp (n=3).  *Significant 
difference vs WT (see Methods).  XG= Mcm9XG743/XG743, p53=Trp53-/-, 
p21=Cdkn1a-/- Error bars indicate Std Dev. 
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Figure 2-6.  Testicular histology of various Mcm9 allelic combinations and 
normal histology in a hypomorphic Mcm2-7 compound genotype. Similar to 
Mcm9XG743 homozygotes shown in Fig. 3, the other Mcm9 alleles and allelic 
combinations show spermatogenesis and germ cell defects: germ cell depletion 
(*); meiotic arrest (^); terminal wave of spermatogenesis (arrow). Circled 
seminiferous tubules are undergoing normal spermatogenesis. Mice with severe 
MCM2-7 depletion have normal spermatogenesis (bottom panel). 
AWO=Mcm9AWO655; XE=Mcm9XE518; XG=Mcm9XG743. C3/C3=Mcm4Chaos3/Chaos3 
M2=Mcm2GT/+. 
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 The sex-independent shortfall of germ cells in peripubertal animals is 
suggestive of a defect early in the germ lineage, possibly during the expansion or 
establishment of germ-line stem cell pools during embryonic development.  To 
test this, 1-day-old control and Mcm9XG743/XG743 gonads were serially sectioned 
and probed with the germ cell-specific marker MVH (mouse vasa homolog).  This 
revealed a 72% decrease of gonocytes in nascent seminiferous tubules (Figure 
2-5G-I), and 82% fewer oocytes in newborn ovaries (Figure 2-5J-L).  Therefore, 
the shortfall in germ cells occurred during gestation.  To determined if germ cell 
loss occurs via TRP53-pathway-mediated elimination, Mcm9XG743/XG743 Trp53-/- 
and Mcm9XG743/XG743 Cdkn1a-/- (Cdk1na = p21) animals were bred and their germ 
cell numbers were scored at 1dpp.  There was no rescue of germ cell depletion 
in either of these compound mutants (Figure 2-5I,L).  Curiously, TRP53 
deficiency actually further decreased the numbers of germ cells in 
Mcm9XG743/XG743 newborn males but not females (Figure 2-5I,L). 
 
MCM9 deficiency does not impact MCM2-7 chromatin loading, has minimal 
impact on genome stability, but predisposes to cancer.   
 Mutations reducing MCM2-7 levels cause genomic instability and cancer 
susceptibility in mice (7, 8) as a consequence of decreased pre-RC formation (6, 
21, 22).  Since it was reported that MCM9 is essential for MCM2-7 loading onto 
replication origins and thus pre-RC formation in Xenopus oocyte extracts (14), 
we tested whether MCM9 depletion impacts MCM2-7 chromatin loading in  
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Figure 2-7. Loss of MCM9 does not alter MCM2-7 or CDT1 levels, however 
leads to mild genomic instability and cell cycle defects under replication 
stress. 
(A) Western blots of mutant and WT MEFS showing detergent soluble vs. 
chromatin bound levels of indicated proteins. (B) Quantification of data in “A.” (C) 
Micronucleus levels in erythrocytes. (D) Chromatid breaks in mutant MEFS.  (E) 
Mcm9 mutant MEFs undergo premature senescence.  Y axis values were taken 
every 3 days upon passage.  (F) Mutant MEFs exhibit a delay in cell cycle entry 
following Aphidicolin-induced replication stress. Primary data are in Fig. S3. 
MEFs were serum-starved to synchronize at G0/G1, serum was then added, then 
measurements were taken. AW = Mcm9AWO655; XG = Mcm9XG743.  The P value is 
based on t-testing. “UN” = measurements 20 hrs after serum addition, but 
untreated with APH; “20 hr APH” = same as previous, but with APH treatment; 
“3hr Rel” or “24hr Rel” = same as previous, but 3 hrs or 24 hrs after APH was 
removed from media (n=3). Error bars indicate Std Dev. 
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Figure 2-8. Sensitivity of MCM9-deficient MEFs to replication stress.  (A) 
Untreated mutant MEFs proliferate normally in unsynchronized cultures.  (B,C) 
BrdU incorporation in unsynchronized MEF cultures. (D,E) Cell cycle profiles of 
MEFs analyzed by flow cytometry.  DNA was stained with Hoescht.  These data 
were plotted in Fig. 4G of text. (F,G).  Cell cycle profiles of MEFs arrested in G1 
by serum starvation, then treated with aphidicolin (Aph) for 3 hours, followed by 
addition of serum (”post-release”)(N=3 for each experiment). 
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Mcm9 AWO655/AWO655 MEFs.  No difference in chromatin-bound MCM2, MCM4, and 
MCM7 was observed (Figure 2-7A,B).  Furthermore, in contrast to Xenopus 
oocyte extracts immunodepleted for MCM9, no decrease of CDT1 was observed 
in mutant MEFs (Figure 2-7A,B). 
 To test for somatic chromosome instability (CIN), we measured peripheral 
blood micronucleus levels, an indicator of CIN that is elevated in Mcm2-7 
deficient mice (6, 8).  Relative to WT, micronucleus levels were marginally higher 
in Mcm9XG743/XG743 but not Mcm9AWO655/AWO655 mice (Figure 2-7C).  We also 
observed a 1.6 fold increase in metaphase chromatid breaks in Mcm9XG743/XG743 
MEFs (Figure 2-7D). 
 Although Mcm9 disruption had no apparent impact on MCM2-7 homeostasis 
in MEFs and only slightly increased chromosomal instability, we aged Mcm9 
homozygotes, compound heterozygotes, and control siblings to assess potential 
long-term health consequences. All mutant males developed tumors by 1 year of 
age (vs. 32-33% of heterozygote and WT controls; Table 2-2).  The most 
remarkable difference compared to controls was in the incidence of 
hepatocellular carcinoma (HCC; 8/13 mutants vs 0/28 controls).  Furthermore, 
8/8 affected animals had multiple HCCs (Table 2-3).  MCM9-deficient females 
were prone to ovarian tumors (10/22 vs 0/12 in controls) by 1 year of age (Table 
2). 
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Table 2-2. Tumor incidence in MCM9-deficient mice 
 
MALES Age          Tumor 
Genotype  (wks) #     N  HCC   HA Oth Free 
WT 40-55  9  ≥N5      0    2  1 67% 
Mcm9GT/+ 40-55 19 ≥N4      0    6  1 68% 
Mcm9GT/GT  40-55 13 ≥N4      8    4  1 0% 
 
FEMALES Age          Tumor 
Genotype (wks) #    N     OvT OvH Oth  Free 
Controls  31-66 12 ≥N2      0    1   1 92% 
Mcm9GT/GT 32-56  7    ≥N2      4    2**   1 29% 
Mcm9GT/GT  9-25 15   <N3      6    3   2 47% 
 
N = # of backcross generations into strain C3H; HCC=hepatocellular carcinoma; 
HA=hepatocellular adenoma; Oth=other tumors; OvT=ovarian tumor; 
OvH=ovarian hyperplasia; WT=Wild-type; GT=Mcm9XE518, Mcm9XG743, or 
Mcm9AWO655.  **OvH in contralateral ovary to tumor.  In females, “Controls” 
include both heterozygotes and WT animals.  Data on all individuals are 
presented in Table S3. 
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Table 2-3. Histopathology of Mcm9 mutant alleles 
Animal 
Number Geno 
Age 
(wks) 
S
e
x Tumors 
Tumor 
size 
(mm) Pathology 
N# 
C3H 
Male Control 
16100, 
16197, 
18414, 
18416, 
18417, 
18418 
WT 52-53 M 0   N5, 
N10 
16802 WT 52 M 1-Liver 6 Hepatocellular adenoma N6 
17877 WT 55 M 1-
Pancreas 
2 Islet Cell Adenoma N7 
18415 WT 52 M 1-Liver 7 Hepatocellular adenoma N10 
17364, 
17365, 
17368, 
19192, 
19193, 
19195 
XE/+ 52-55 M 0   N5, 
N10 
19194 XE/+ 52 M 1-Liver 18 Hepatocellular adenoma and 
enlarged spleen with lymphoid 
hyperplasia 
N10 
17099 XE/+ 52 M 1-Liver, 1-
Lung 
6 and 1 Hepatocellular adenoma and hepatic 
lipidosis; Lymphoid hyperplasia in 
thymus (possible lymphoma); 
pulmonary adenoma 
N5 
15639, 
15640 
XG/+ 40 M 0   N4 
16801,17
359,  
17360, 
17367 
XG/+ 52-55 M 0   N6 
17875 XG/+ 55 M 0  Lipidosis, Ito cell hyperplasia of the 
liver, reactive cervical lymph node 
N7 
16101 XG/+ 52 M 1-Liver small Hepatocellular adenoma N5 
16198 XG/+ 53 M 1-Liver 21 poor histological section N5 
16196 XG/+ 53 M 1-Liver 22 Hepatocellular adenoma N5 
17874 XG/+ 55 M 1-Liver 16 Hepatocellular adenoma with 
hepatocyte disorganization, 
vacuolation, lipidosis 
N7 
Male Mcm9GT/GT 
17097 XG/XE 52 M Mult Liver 27 Hepatocellular adenoma with 
vacuolar change 
N5 
17098 XG/XE 52 M 3-Liver 15, 4, 
and 1 
Hepatocellular adenoma with 
vacuolar change 
N5 
17366 XG/XE 55 M 4-Liver 24,12, 
7, and 
2 
Hepatocellular Carcinoma N5 
16798 XG/XG 52 M 3-Liver 22, 12, 
and 4 
Hepatocellular Carcinoma N6 
16103 XG/XG 52 M 3-Liver 18, 9, 
and 5 
Hepatocellular Carcinoma N5 
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17361 XG/XG 56 M 3-Liver 19, 5, 
and 5 
Hepatocellular Carcinoma N6 
17876 XG/XG 55 M 2-Liver 22 and 
16 
Hepatocellular Carcinoma N7 
16102 XG/XG 52 M 3-Liver 19, 14, 
and 5 
Hepatocellular Carcinoma N5 
16099 XG/XG 52 M 3-Liver 24, 18, 
and 5 
Hepatocellular Carcinoma, N5 
16800 XG/XG 52 M Mult. sm. 
liver 
1 to 2 
mm 
Hepatocholantiocellular Carcinoma N6 
15641 XG/XG 40 M 2-Liver 15 and 
3 
Hepatocellular adenoma and 
thrombus 
N4 
16195 XG/XG 53 M 2-Liver, 1-
Lung 
15, 9, 
and 2 
Hepatocellular adenoma with 
vacuolar change, Lung Adenoma, 
cardiac muscle in pulmonary 
arteries 
N5 
16799 XG/XG 52 M 1-Testis 3 Interstitial cell tumor of the testis N6 
Female Control 
13116 WT 45 F   Large follicular cyst N9 
17250 WT 54 F    F2 
17251 WT 54 F    F2 
18352 WT 56 F   Unilateral atrophy/involution of the 
ovary 
N7 
17863 WT 66 F    N11 
11549 XE/+ 41 F    N5 
13882 XG/+ 31 F    N4 
21247 XG/+ 32 F   Enlarged spleen with lymphoid 
hyperplasia 
N10 
18356 XG/+ 52 F   Papillary cyst with hyperplasia and 
mineralization 
N7 
18359 XG/+ 52 F   Hepatic lipidosis, Cutaneous 
fibropapilloma 
N7 
18351 XG/+ 56 F   Small follicular cyst, Adenomyosis 
of the uterus 
N7 
10840 XG/+ 57 F 1-Lung 1.5 Lung Carcinoma, Mild lipidosis, 
hepatitis, necrosis of the liver 
N2 
Female Mcm9GT/GT 32-56wks 
21246 XG/XG 32 F   Mild multifocal hepatic lipidosis, 
mild multifocal infiltrats of 
lymphocytes in the pancreas 
N10 
20543 XG/XG 43 F 1-
Mammary 
9 Mammary adenocarcinoma, mild 
lymphoplasmacytic metritis 
N10 
16110 XG/XG 44 F 1-Ovary  Cystadenoma and tubulostromal 
hyperplasia 
N2 
16111 XG/XG 44 F 1-Ovary  Papillary cystadenoma and 
tubulostromal hyperplasia 
N2 
18357 XG/XG 52 F   polycystic ovaries N7 
18358 XG/XG 52 F 1-Ovary  Benign mixed sex cord tumor N7 
18353 XG/XG 56 F 1-Ovary 9 Granulosa cell tumor, epithelial 
metaplasia 
N7 
Female Mcm9GT/GT 9-25wks 
21371 XG/XE 11 F   Tubulostromal hyperplasia, 
Lymphoid hyperplasia, Enlarged 
F3 
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lymph nodes (reactive?) 
21373 XG/XE 11 F    F3 
21374 XG/XE 11 F   Enlarged lymph nodes (reactive?) F3 
21237 XG/XE 14 F 1-Ovary Large Ovarian teratoma and enlarged 
spleen with lymphoid hyperplasia 
F3 
21681 XG/XE 17 F   Focal tubulostromal hyperplasia, 
Enlarged lymph node (reactive?) 
F3 
21754 AW/XG 12 F Lymphom
a 
 Lymphoma and enlarged spleen 
with lymphoid hyperplasia 
N2 
21235 AW/XG 14 F 1-Ovary  Tubulostromal ovarian adenoma F3 
21238 AW/XG 14 F    F3 
21682 AW/XG 17 F 1-Ovary, 
Lymphom
a 
11 Ovarian teratoma, Lymphoma, and 
enlarged spleen with lymphoid 
hperplasia; mixed inflammatory 
cells in mesentery 
F3 
21680 AW/XG 17 F    F3 
21683 AW/XG 17 F Possible 
Lymphom
a 
 Enlarged lymph node (possible 
lymphoma) 
F3 
21105 AW/XG 25 F 1-Ovary  Tubulostromal ovarian adenoma F2 
21455 AW/AW 9 F   Tubulostromal 
hyperplasia,Neutrophilic 
peribronchial infiltrates in lung 
F2 
21362 AW/AW 13 F 1-Ovary  Tubulostromal ovarian adenoma, 
Enlarged pancreatic lymph node 
(reactive?) 
F2 
21364 AW/AW 13 F 1-Ovary  Tubulostromal ovarian adenoma F2 
Legend.   XE=Mcm9XE518, XG=Mcm9XG743, AW=Mcm9AWO655.  N# C3H = Backcross generation 
into C3HeB/FeJa. 
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MCM9 deficiency does not perturb the cell cycle, but does delay cell cycle 
re-entry following replication stress.   
 To determine if Mcm9 deficiency alters the cell cycle as does depletion of 
MCM2-7 (8, 23), Mcm9XG743/XG743 primary MEFs (made from C3H congenic 
embryos) were evaluated under normal or replication stressed conditions.  
Continuous cultures of early passage cells were no different than WT with 
respect to proliferation, BrdU incorporation, and cell cycle profile (Figure 2-8A-E).  
However, the mutant cultures underwent senescence prematurely (by passage 
5), ultimately producing immortalized survivors (Figure 2-7E).  When 
Mcm9XG743/XG743 and WT MEFs were synchronized at G0/G1 by serum starvation, 
then released (by serum addition) in the presence of aphidicolin (APH), APH-
treated (but not untreated) mutant cells exhibited a delay in progression from 
G0/G1 through S-phase (Figure 2-7F; Figure 2-8G).  These results confirm that 
MCM9 is dispensable for unperturbed DNA replication in mouse cells, but its 
absence accelerates senescence and confers susceptibility to DNA replication 
stress. 
 
2.4 Discussion 
Mcm9 encodes at least 2 isoforms, however the collection of mutant alleles 
reported here shows that neither is necessary for pre-RC formation or DNA 
replication in mice or mouse cells.  This result was surprising, given a report that 
MCM9 is essential for loading MCM2-7 and thus formation of pre-RCs and DNA 
replication in a Xenopus egg extract system (14).  In this widely-used model, 
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sperm DNA added to the extract gets converted into chromatin, and a single 
round of replication ensues in a putatively physiological manner.  That study 
found that MCM9 binds to chromatin in an ORC-dependent manner, and by 
virtue of interacting directly with the essential helicase loading factor CDT1, 
enables MCM2-7 assembly into pre-RCs.  Evaluation of MCM9’s role was 
determined by immunodepletion, and supplementation of immunodepleted 
extracts with in vitro-produced Mcm9 mRNA partially rescued MCM2-7 loading 
and the block in DNA replication. 
 We can offer theories on these contradictory data.  First, amphibians and 
mammals may differ in the need for MCM9 in DNA replication, such that whereas 
it is essential in Xenopus, it has acquired a more specialized (e.g., germ-line 
stem cells), but non-essential role in mammals.  In this regard, it should not be 
overlooked that the Xenopus oocyte is a specialized cell.  Many eukaryotes lack 
Mcm9 (and Mcm8) which supports the idea that MCM9 evolved to have a 
specialized role, rather than an essential one for DNA replication in some 
species.  Second, the Xenopus egg extract system may not be entirely accurate 
in recapitulating all aspects of DNA replication and its regulation.  Third, it is 
possible that, despite rigorous controls (14), that the MCM9 immunodepletion 
had an unknown, deleterious effect upon pre-RC formation.  Furthermore, since 
CDT1 interacts directly with MCM2-7 in vivo (24), MCM9 would not be required to 
mediate the essential CDT1:MCM2-7 interaction needed for loading.  Whatever 
the reason for the disparity in results, the present study underscores the 
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importance of in vivo genetic ablation studies to reveal the true physiological role 
of genes in the context of a whole animal. 
 Although Mcm9 is ubiquitously expressed, its ablation appears to affect only a 
subset of tissues in the mouse under normal laboratory conditions.  There were 
two major phenotypes: germ cell depletion and cancer susceptibility.  The 
observed germ cell loss appears to occur at two stages.  The shortfall observed 
at birth must have its roots in: a) the specification or proliferation of the primordial 
germ cell (PGC) lineage; b) migration of the PGCs to the genital ridges and 
primitive gonads; or c) proliferation within the primitive gonads.  This germ cell 
proliferation happens rapidly, expanding the number from ~100 to >20,000 (25).  
Alternatively, PGCs may get depleted due to a failure in maintenance after 
migration to the primitive gonads.  The second stage of loss is specific to males, 
where there appears to be a defect in spermatogonial self-renewal during 
adulthood.  How MCM9 deficiency causes these defects is not clear.  Although 
MCM9 is related to the MCM2-7 replicative helicase proteins, we do not believe 
that overall DNA replication per se is impaired, since severely hypomorphic 
MCM2-7 mutations do not have germ cell defects.  Rather, we conjecture that 
given the observed phenotypes of cancer susceptibility, GIN, and replication 
stress sensitivity, that MCM9 deficiency causes a subtle defect in repair of 
replication-induced damage to which rapidly proliferating germ-line stem cells are 
especially sensitive. If true, this might trigger cell death as a means to prevent 
transmission of a compromised genome to offspring. However, like DNA 
damage- or replication stress-induced apoptosis of ES cells (26), such death 
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would have to occur via a TRP53 –independent pathway as indicated by our 
genetic studies.  Alternatively, the progressive loss of spermatogonial stem cells 
in adult male Mcm9 mutants points to stem cell maintenance or proliferation 
defects.  Future experiments will be geared towards identifying the stages at 
which germ cells are being lost during development, and what cell cycle and/or 
damage checkpoint pathways might be activated to cause their elimination or 
failure to proliferate. 
 Interestingly, Mcm9 mutant mice were susceptible to distinct sex-specific 
cancers.  Males were highly prone to hepatocellular carcinomas (HCC).  In 
humans, HCC is more common in males than females (27).  The majority of HCC 
mouse models are driven by viral induction, drug treatments, deregulated 
oncogenes, or a combination of these (28, 29).  We are aware of only one germ-
line mutation (Abcb4/Mdr2) that causes a high incidence of HCC formation with 
<1 year latency (30).  Therefore, the Mcm9 mutants may provide a useful model 
for genetic susceptibility to HCC.  Mutant females were prone to ovarian tumors, 
although these may be related to germ cell depletion and premature ovarian 
failure (31).  In conclusion, MCM9 depletion drives neoplasia by a mechanism 
that does not seem to involve a major increase in chromosome instability or 
disrupted loading of MCM2-7 onto pre-RCs.  However, the delayed ability of 
mutant MEFs to re-enter the cell cycle following Aph treatment suggests that 
certain cell types may have a sensitivity to replication stress, and this may play a 
role in the cancer susceptibilities. 
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2.5 Materials and Methods 
Mice.  Gene trap-bearing ES cell lines (from 129 substrains) ware obtained from 
BayGenomics (XG743 and XE518) and The Sanger Institute (AWO655 and 
ALO673). Chimeras were generated by microinjection of the ES cells into 
C57BL/6J blastocysts using standard procedures.  Following germ-line 
transmission, alleles were backcrossed into C3HeB/FeJa (“C3H”). Exact insertion 
sites of gene trap vectors were determined by “primer walking” as described (6, 
8).  Genotyping of was performed either by PCR amplification of the neo gene 
within the vector, by insertion-specific assay, or utilizing polymorphic flanking 
microsatellite markers D10Mit20 and D10Mit194 that are polymorphic between 
129 and C3H (Table S1). 
Histology and immunohistochemistry.  For basic histology, tissues were fixed 
in 4% paraformaldehyde overnight, paraffin embedded, sectioned, and stained 
with hematoxylin and eosin (H&E).  For germ cell counts, 10µM sections of 1 day 
old gonads were immunostained as described (32). Antibodies: Rabbit anti-
DDX4/MVH (Abcam ab13840, 1:250); goat anti-rabbit Alexa 488 conjugate 
(Molecular Probes A11008, 1:1000).  Germ cells were counted in three sections 
from the midportion of each gonad and averaged.  The data were analyzed using 
one-way ANOVA with Bonferroni correction (Prism software package).  The 
resulting P values were used to determine significance (P<0.05). 
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RT-PCR and cDNA analysis.  Semi-quantitative PCR analysis of various mouse 
tissues (Fig. 1c) was performed on the Mouse Multiple Tissue cDNA panel from 
Clontech (636745).  Real-time RT-PCR was performed as described (6, 8).  
Oligonucleotide primers are listed in Supplemental Table S1. 
MEF growth studies.  MEF growth analyses and metaphase spreads were 
performed as described (33).  For senescence assays, cells were counted every 
3 days and replated at 5X105.  All MEFs were derived from C3HeB/FeJ congenic 
(N10) embryos and were primary cultures. 
Micronucleus assays.  These were performed essentially as described (34). 
Isolation of protein fractions.  For Western analyses of chromatin bound vs 
non-chromatin-bound proteins, we used a Triton-100 detergent fractionation 
protocol.  Briefly, MEFs were trypsinized, washed twice in cold PBS, 
resuspended by vortexing in 1ml TX-NE (320 mM sucrose, 7.5 mM MgCl2, 10 
mM HEPES, 1% Triton X-100, plus protease inhibitor), and incubated on ice for 
30 min.  Nuclei were pelleted (1200 RPM, 3 min) and the supernatant, containing 
proteins of cell membrane, cytosolic, and free forms of MCMs, was designated 
as the detergent “soluble” fraction (23, 35).  The nuclear pellet was resuspended 
in 0.5ml RIPA, liberating the chromatin fraction containing nuclear scaffold 
proteins, DNA, and chromatin binding forms of MCMs.  Antibodies used were as 
follows.  MCM2: ab31159 (Abcam); MCM7: ab2360 (Abcam); Beta-actin: A1978 
(Sigma); Fibrillarin: ab5821 (Abcam), CDT1: 06-1295 (Millipore), GAPDH: 6C5 
(Advanced Immunochemical). 
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APPENDIX I 
2.7 Additional MCM9 data 
To investigate further into the testicular phenotype that we observed 5% of 
the seminiferous tubules contained cells that were in meiotic arrest, we 
performed meiotic surface spreads.  Using antibodies against γ-H2AX and 
RAD51 on pachetene spermatocytes there was a persistence of both at 38% and 
31% respectively (Figure A1-1A-F).  This indicates there is still unrepaired DNA 
damage in these cells.  However this does not correspond to the 5% of tubules 
arrested in meiosis, so a subset of these cells must eventually go on to repair the 
damage and complete meiosis or undergo apoptosis.  To quantify the apoptosis 
levels in Mcm9XG743/XG743 animals, TUNEL assays were performed.  We observed 
a 1.6 fold increase in TUNEL positive cells in the mutant over the control testes 
(Figure A1-1G-I).  This is only a slight but significant increase over WT with the 
spread of TUNEL positive cells in the interior of the tubule and not near the basal 
lamina where the stem cells reside.  This indicates that the cells that are being 
lost are not the stem cells population. 
Since there appears to be a spermatogonial stem cell defect, we wanted 
to see if the stem cell loss could extend to other populations.  So we tested the 
induced pluripotent stem cell (iPS) induction potential of the Mcm9XG743/XG743 
MEFS.  The mutant cell lines were significantly induced at a lower rate by metric 
of colony formation than the wild-type lines (p<0.001 TTEST) (Figure A1-2). 
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Figure A2-1 Persistent double strand breaks in MCM9 mutant Spermatocytes and 
increased apoptosis in seminiferous tubules. 
 Surface spread spermatocyte nuclei were immunostained with SYCP3 for the central 
element in red (A-F) and γ-H2AX (A-C) and RAD51 in green (D-F). (G-I) There is an 
increase in TUNEL positive cells in the MCM9 mutant testes (H,I). TUNEL (RED) 
counterstained with DAPI. 
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Figure A2-2 Decreased iPS effenciency in MCM9 mutant cells. 
The number of colonies formed by Mcm9XG/XG cell lines were significantly decreased 
from wild-type. 
      
 
These results indicate that while spermatogenesis is occurring in these 
mice, the set of problems that we have observed is not due to just one defect.  
There is only a slight increase in apoptosis occurring, however 1/3 of the 
pachytene cells contain persistent DNA damage.  This suggests that the damage 
may be getting repair, or that the damaged cells are being removed by other 
methods not involved in apoptosis.  There may be an over-proliferation of the 
early spermatogonial stem cell that could lead to premature senescence or 
terminal differentiation. 
The decrease transformation of MEFs into iPS cells may be due to the 
inability of Mcm9XG743/XG743 to maintain stem cell properties. This decrease may 
also be due to the cell cycle of the MEFs, such that the stress casued by the viral 
induction interferes with the cell cycle in a way that MCM9 is needed, and this 
leads to fewer cells that can be transformed. 
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Geminin is the negative interactor of CDT1.  One of geminin’s other roles 
is involved in differentiation.  Geminin in the testes is only expressed in 
differentiated cells.  Leading to a hypothesis that Mcm9 may be a “stemness” 
factor at least in the testes. Not only does geminin have a role in suppressing  
CDT1 to prevent formation of a pre-RC during DNA replication, geminin has roles 
in balancing DNA replication with differentiation(1) 
 
METHODS: 
Meiotic spreads were performed as described(2). The primary antibodies used 
were as follows: mouse anti-SCP3 (1:500; Abcam); rabbit anti-RAD51 (1:250, 
this polyclonal antibody recognizes both RAD51 and DMC1; Oncogene Research 
Products); rabbit anti-γH2AX (1:500; Upstate Biotechnology).  
 
For immunohistochemistry, the sections were deparaffinized and dehydrated 
through Xylene/Ethanol/PBS gradients. Slides were subjected to antigen retrieval 
by boiling at 95o C for 40 minutes in 10mM Tris-sodium citrate/PBS (pH=6.0) 
with 0.05% Tween 20. Mouse monoclonal anti-PCNA antibody (clone PC10; 
Sigma; diluted 1:200), and conterstained with DAPI. 
 
Induced pluripotent stem cells were made as previously described (3). 
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3.1 Abstract 
Fanconi Anemia (FA) is a rare human genetic disorder characterized by 
bone marrow failure, developmental abnormalities, decreased fertility, and high 
incidence of malignancies.  The FA complementation group has roles in 
resolution of DNA interstrand crosslinks. The role of FANCM in FA crosslink 
repair is as part of the damage sensor and loads the FA core complex to the site 
of the DNA interstrand crosslink.  FANCM also participates in the S-phase 
checkpoint through signaling with ATR, and FANCM has FA complex-
independent roles in DNA damage repair.  Our lab conducted an ENU 
mutagenesis screen for animals with elevated genomic damage in peripheral 
blood.  From this screen we recovered an allele, chaos4, which contains a point 
mutation in a highly conserved amino acid within the helicase domain of FANCM.  
We also created a gene-trap allele that removes the endonuclease domain of 
FANCM.  Phenotypic analysis revealed that these mutants share some 
phenotypes with each other and the published null Fancm mouse.  There are 
also a number of phenotypes unique to each of these mutant mice.  Subsets of 
these mutants have germ cell depletion and a G2/M delay in primary MEFs.  
Meanwhile none of our Fancm mutant cells are sensitive to MMC. These data 
suggest that these different alleles may allow for separation of function analyses 
of the translocase and endonuclease domains of FANCM.  
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3.2 Introduction 
The Fanconi Anemia complementation group currently consists of 15 
genes.  The complementation group can be sub-divided into 3 components, the 
core complex, the ID group, and the repair group.  The core complex consists of 
FANC-A,B,C,E,F,G,L, and M (1, 2). The core complex is loaded onto the site of 
DNA damage partially by FANCM (3). Then the core complex acts as an E3 
ubiquitin ligase with the E2 protein UBE2T to mono-ubiquitinate the ID 
heterodimer that consists of FANCD2 and FANCI (4, 5).  The mono-ubiquitination 
of FANCD2 and FANCI then allows for the activation of the repair group 
constisting of BRCA2/FANCD1, FANCN, FANCJ, FANCO (RAD51C) and 
possibly FANCP (SLX4). These proteins have roles in homologous 
recombination and translesion synthesis (6–9).  This activation of the FA pathway 
is in conjunction with activation of the ATR pathway which phosphorylates a 
number of the FA proteins (10–12).  FANCM has a role in stabilizing ATR 
through its interaction with HCLK, and it also participates in RPA localization to 
sites of ssDNA (6–8, 13, 14). The overall role of the Fanconi Anemia complex is 
to preserve genome stability.  This is accomplished through processing blocked 
and/or broken replication forks through the coordination of homologous 
recombination and translesion synthesis. (9). 
There are several knock-out (KO) mouse models of the Fanconi Anemia 
complementation group. They all have similar phenotypes including germ cell 
depletion and sensitivity to MMC, however only a subset have congenital defects, 
and only one (FANCP/SLX4) recapitulates hematopoietic defects that are 
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characteristic of the human disease (9, 15).  Fancd2 mouse mutants have been 
shown to exhibit a higher incidence of cancer (15).  The Fancm deletion mouse 
exhibits germ cell depletion, sensitivity to MMC, and a high incidence of cancers. 
In contrast to other FA mutants is that intercrosses of Fancm-/- animals yield a 
non-Mendelian ratio of female offspring.  Homozygous Fancm-/- cells exhibit a 
high incidence of sister-chromatid exchange (SCE), and a decreased ability to 
mono-ubiquitinate FANCD2 (16).  As a core complex member, FANCM unique 
from the other FA core members as it is conserved through evolution as it has 
homologues in yeast and archaea. Furthermore, unlike other FA gene mutations, 
Fancm cell lines also have sensitivity to UV (activates nucleotide excision repair) 
and camptothecin (CPT, activates double stranded break repair) (10). This all 
suggests that FANCM has roles in DNA repair pathways in addition to interstrand 
crosslink repair. 
FANCM has 2 conserved domains: a helicase/translocase domain and an 
endonuclease domain, but neither of these have any known helicase or 
endonuclease activity (17). Additionally, FANCM contains three known protein 
binding motifs, MM1, MM2, and MHF (18–20). The biochemical roles of these 
domains and motifs are the subject of ongoing investigations.  The overall role of 
FANCM appears to be binding chromatin and localizing the FA core complex to 
the site of DNA damage. However, FANCM can facilitate holliday junctions (HJ) 
branch migration, and possess fork reversal activity that may facilitate template 
switching during lesion bypass (21–23).  FANCM has been shown to be involved 
in D-loop dissociation, and has translocase activity to allow movement along 
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DNA (21, 24, 25). FANCM interacts with ATR through HCLK (which stabilizes 
ATR).  This interaction suggests that FANCM may be part of the S-phase 
checkpoint (6, 7, 26). Most of these functions mentioned above are facilitated 
through the helicase/translocase domain of the protein with some overlap with 
the endonuclease domain. 
The C-terminal endonuclease domain of FANCM is needed for its 
interaction with its binding partner FAAP24 (which also has an endonuclease 
domain).  Both are required, at least partially, for interaction with the FA core 
complex.  Both the interaction with FAAP24 and the endonuclease domain are 
needed for resistance to CPT, but not for resistance to MMC, cisplatin or mono-
ubiquitination of FANCD2. FAAP24 does increase FANCM binding specificity to 
certain DNA structures (3, 6, 7, 27). 
The FANCM histone fold motif (MHF) binds to MHF1 (CENP-S) and MHF2 
(CENP-X).  The binding to these proteins localizes FANCM to the chromatin and 
possibly to the centromere.  This interaction is also important for FANCD2 mono-
ubiquitination and foci formation, as well as resistance to MMC and CPT(18, 19).   
Two other binding motifs are FANCM Motif 1 and 2 (MM1, MM2) which are 
important in tethering the FA core complex members and the HR repair complex 
of BLM respectively (20). 
Recently FANCM has been shown to have some functional redundancy 
with the MutS homologues which are important for mismatch repair (28).  All of 
these activities of FANCM suggest that it is involved in multiple DNA repair 
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processes, from sensing DNA damage to choice and recruitment of repair 
pathways to actually facilitating the repair itself. 
 Given the importance of FANCM for the functioning of the FA core 
complex, and the roles of FANCM in DNA repair, these studies are aimed at 
understanding FANCM functions in various cellular contexts.  We accomplish this 
through the use of two mutant alleles of Fancm that have hypomorphic function 
with respect to the different domains of FANCM. 
 
3.3 Results 
 
Identification of Chaos4, an allele of Fancm, from a screen for mutations 
causing genomic instability (GIN): 
Chromosomal aberrations occurring spontaneously 4 (Chaos4) arose from 
an ENU mutagenesis screen for mouse mutations causing GIN (29). The screen 
used elevated micronuclei (MN) in peripheral blood as a marker for GIN.  Chaos4 
mutant animals had a 0.43% micronucleus level, representing an approximately 
3 fold increase over the WT (0.14%; Figure 3-1A).  Using the SNP mapping 
service from the Beier Lab (30), we localized the mutation to a 44Mb region on 
mouse chromosome 12. Microsatellite markers further reduced the region to a 
14Mb region between D12Mit285 and D12Mit71. Using elevated micronuclei as  
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Figure 3-1 Chaos4 is an allele of Fancm. 
A. Representative flow cytometric plots of Wild-Type (left) and FancmC4/C4 (right). 
Micronucleated erythrocytes are the population positive for propidium iodide 
(lower right quadrant). On the far right are total quantification of MN in wild-type 
(WT), FancmC4/C4 (C4/C4), FancmC4/XH (C4/XH), and FancmXH/XH (XH/XH) mutant 
alleles. B. The critical recombinant animals with black=B6, grey=B6/C3H, 
white=C3H. C. Genes on mouse chromosome 12 within the critical recombinant 
region. D. Fancm showing location of T524C point mutation in first exon (arrow), 
insertion of the XH297Genetrap in the 14th exon (blue triangle). Below is the 
Sanger sequence trace of wild-type (WT), FancmC4/+ (C4/+), and FancmC4/C4 
(C4/C4). E. FANCM showing location of the C142R a.a. change in the 
helicase/translocase domain (arrow) and insertion of the gene-trap (blue 
triangle). Below shows the conservation of the amino acid. 
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the phenotype, recombination mapping was pursued and 956 meioses were 
scored.  Nine critical recombinants narrowed the region to 9 Mb between 
RS13481482 and D12MIT71 (Figure 3-1B) containing 9 RefSeq annotated genes 
(Figure 3-1C).  Fancm was a strong candidate, as it is part of the Fanconi 
Anemia complementation group known to be important in DNA crosslink repair.  
DNA Sanger sequencing revealed a T524C transition in Chaos4 (Figure 3-1D).  
This point mutation leads to a non-synonomous cysteine to an arginine (C142A) 
change in a highly conserved amino acid in the helicase domain (Figure 3-1E). 
To test if Chaos4 is indeed an allele of Fancm, we created mice carrying a 
gene-trap in Fancm from BayGenomics.  The XH297 (FancmXH) gene-trap 
insertion is located distal to the helicase domain but upstream of the 
endonuclease domain (Figure 3-1D,E).  Homozygous gene-trap animals have 
elevated MN (Figure 3-1A).  Compound heterozygotes (FancmC4/HX) they did not 
complement by analysis of micronuclei levels (Figure 3-1A).  Therefore, Chaos4 
(FancmC4) is an allele of Fancm. 
 
Sex skewing and subviability associated with the FancmXH mice. 
The published knock-out allele of Fancm is associated with a decreased 
number of females born from heterozygous intercrosses (16).  While the 
FancmC4/C4 and FancmC4/XH mice had expected numbers of animals born (χ2 p-
value of 0.48 and 0.36 respectively), the FancmXH/XH mice have a significant 
decreased number of female pups and an elevated number of male pups (χ2 p-
value of 0.047). More  
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Table 3-1 Viability of mice with indicated Fancm alleles 
     
 Male Female Combined  
 Obs Exp Obs Exp Obs Exp N10 
C4/C4 40 44 52 44 92 88  
C4/+ 81 88 84 88 165 175  
WT 49 44 44 44 93 88  
        
χ2 p-value 0.48  0.43  0.56   
        
 Male Female Combined  
 Obs Exp Obs Exp Obs Exp <N5 
XH/XH 12 8 5 8 17 16  
XH/+ 10 16 15 16 25 33  
WT 12 8 11 8 23 16  
        
χ2 p-value 0.05  0.31  0.10   
        
 Male Female Combined  
 Obs Exp Obs Exp Obs Exp <N5 
C4/XH 2 3 4 3 6 6  
C4/+ 1 3 2 3 3 6  
XH/+ 5 3 3 3 8 6  
WT 4 3 4 3 8 6  
        
χ2 p-value 0.36  0.83  0.44   
        
     
Obs=Observed, Exp=Expected, C4=FancMChaos4 ,  XH=FancMXH297, N= number 
of generations into the C3Heb/FejA strain background. χ2 p-value is significant 
below 0.05. 
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Figure 3-2. Decreased body size in FancmXH/XH mice. 
A. Male littermates of a FancmXH/+ intercross at 24 weeks. Arrows point to 
FancmXH/XH animals that were noticeably smaller.  B-E Weights and body lengths 
separated by male (B,C) and female (D,E) n=>10, combined weights and lengths 
after 12wks of age is shown.   * is significant (p<0.05 TTEST) throughout the 
animals lifespan, and  decrease in body size ** is significant only after 1 yr of 
age. Wild-type (WT), FancmC4/C4 (C4/C4), FancmC4/XH (C4/XH), and FancmXH/XH 
(XH/XH) mutants. 
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FancmXH/XH animals need to be evaluated to see when in gestation the loss/gain 
is occurring (Table 3-1). 
 
Body size differences are more prominent in the FancmXH/XH mice than the 
other Fancm mutants. 
While there were no overt or visible phenotypes seen in these mice, it was 
observed that the FancmXH/XH males animals had a lower body weight and 
shorter body length as early as 12 wks.  These differences compared to WT 
animals persisted throughout their lifetimes (TTEST p=0.006 and 0.002 
respectively) (Figure 3-2A-C).  Similar to the males, the FancmXH/XH females had 
a significant decrease in body weight and length (p=0.03 TTEST and p=0.02 
TTEST respectively) (Figure 3-2D,E). The FancmC4/+ and FancmC4/C4 males did 
have a decrease in body weight and length once they were >1yr of age (TTEST 
FancmC4/+ p=0.0001 and 0.002, FancmC4/C4 p<<0.0001 for both) (Figure 3-2B,C), 
however compound heterozygotes had neither of these defects (TTEST p=0.89 
and 0.39 respectively) (Figure 3-2B,C).  The FancmC4/C4 females also had a 
suggestive decrease in body length (P=0.08 TTEST) (Figure 3-2D,E).  There was 
no disparity in body weight or body length published in the FancmKO allele(16).   
 
Germ cell depletion occurs in the FancmC4/C4 mice, but not the FancmC4/XH 
or FancmXH/XH mutant mice. 
Since all of the Fanconi Anemia mouse models as well as the FancmKO 
have germ cell depletion, these mice were evaluated for germ cell loss.  The only  
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Figure 3-3 Decrease in testis size in FancmC4/C4 
A-D Testes section (10X) of 12 wk old males of indicated genotypes. C-D 
examples of phenotypes seen in all males of mutant genotype. E-G Testes 
section of males >1yr of age showing meiotic arrest and testicular degeneration 
in FancmC4/C4 males. ^ Giant multinucleated cells, * Meiotic arrested tubule. # 
Terminally differentiated spermatogenesis. H-I Quantification of testes weight 
and sperm count, * significant difference p<0.05 by TTEST was seen in the 
FancmC4/C4 males. Wild-type (WT), FancmC4/C4 (C4/C4), FancmC4/XH (C4/XH), 
and FancmXH/XH (XH/XH) mutant alleles. n>10.   
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Figure 3-4 Meiotic spreads showing unrepaired DNA damage in FancmC4/C4 
spermatocyte nuclei. 
Surface meiotic spreads of spermatocyte nuclei were immunostained with 
SYCP3 for the central element in red (A-H) and γ-H2AX (A-D) and RAD51 in 
green (E-H). A,E WT examples of normal distribution of γ-H2AX and RAD51 in 
meiotic spreads at pachynema/diplonema at the XY sex body.  B, F shows 
normal localization in FancmC4/C4 mutants, however in a subset of spreads there 
is abnormal localization showing either unpaired chromosomes (C), or 
unrepaired/persistent DNA breaks (D,G,H). 
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genotype that was associated with a significant decrease in testes weight and 
sperm count was FancmC4/C4 (p<<0.0001 and p=0.01 respectively by 
TTEST) (Figure 3-3H-I).  Histology sections revealed several abnormalities within 
testes of young, not inbred, FancmC4/C4 males, namely germ cell depletion (GCD) 
(not shown).  However as they became more inbred into the C3Heb/FejA genetic 
background, this phenotype was lost. In testis cross-sections of inbred 
FancmC4/C4 mice, there were giant multinucleated cells (GMC), tubules that 
appears to be missing a wave of spermatogenesis, and tubules that appear to be 
stalled in meiosis with no postmeiotic cell types (Figure 3-3B).  While animals 
bearing the FancmXH/XH and FancmC4/XH genotypes had most of these 
phenotypes except for the GCD that was observed in less inbred mice (Figure 3-
3C,D). Interestingly, as the FancmC4/C4 males aged, the majority of the tubules 
appears to be arrested in meiosis and undergoing testicular degeneration. 
However, in the testes of FancmXH/XH males normal spermatogenesis remains 
intact (Figure 3-3E-G).  
The potential meiotic arrest seen in a subset of tubules was further 
explored in 10wk old FancmC4/C4 males by analyzing surface-spread preparations 
of meiotic chromosomes.  Staining with γH2AX (indicator of DSBs and unpaired 
chromosomes) and SYCP3 (a marker of axial elements of meiotic chromosomes) 
revealed persistent γH2AX staining with mispaired/unpaired chromosomes in 
42% of the spreads analyzed (Figure 3-4A-D).  This correlates with 27% of nuclei 
having persistent RAD51 (localizes to DSBs) foci (Figure 3-4E-H), which  
 
79"
  
Figure 3-5 Decreased Follicles in FancmC4/C4 ovaries. 
A-D Representative images of 12-24 wk old ovary at 10x of given genotype 
(cross-sections may vary). Wild-type (WT), FancmC4/C4 (C4/C4), FancmC4/XH 
(C4/XH), and FancmXH/XH (XH/XH) genotypes.   ARROWS point to primordial or 
primary follicle. N. Quantification of follicles per section. n>10 for each genotype."
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indicates unrepaired DNA damage, however more animals do need to be 
evaluated due to a low N-number of 2 animals per genotype.FancmC4/C4 ovaries 
exhibit a significant age-dependent decrease in number of follicles compared to 
wild-type and the 2 other Fancm mutant mouse alleles (TTEST FancmC4/C4 
p=0.002, FancmC4/XH p=0.29, FancmXH/XH p=0.12) (Figure 3-5.) 
 
Germ cell loss in FancmC4/C4 is p53 dependent and FancmC4C4 is 
synthetically lethal with Atm-/- 
  With the decreased testes weight and some GCD tubules noted in 
FancmC4/C4 males, we want to see if there is a decrease in the germ cell 
population at birth before reactivation of proliferation of the gonocytes. In the 
FancmC4/C4 males there was a significant decrease in the number of germ cells 
per tubule as quantified with MVH (a marker of germ cells) staining (p=0.002), 
suggesting the loss of germ cells occurred before birth (Figure 3-6A-C).  
Since germ cell loss could be due to apoptosis during formation, migration, and 
population of the germ cells in the gonad we conducted genetic crosses with 
DNA checkpoint and repair mutants. The first double mutant is with Trp53, a 
transcription factor when activated ultimately induces apoptosis when DNA repair 
is incomplete.  FancmC4/C4; Trp53-/- double mutants rescues the germ cell loss 
(p=0.005, Figure 3-6F), suggesting that some type of DNA damage is triggering 
cell death.  Consistent with this result, the double mutant with Cdkn1a, a 
downstream target of TRP53 involved in cell cycle arrest, also rescues the germ 
cell loss (p=0.03, Figure 3-6G). 
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Figure 3-6 Depleted Germ Cells at 1dpp in FancmC4/C4, with this loss being 
dependant on S-phase checkpoint signaling. 
A-B 1 day post-partum testes stained with DAPI-blue and VASA (MVH)-green 
(germ cells) of given genotype. C Quantification of germ cells at 1dpp in 
FancmC4/C4 males.  D-G  Genetic crosses of FancmC4/C4 with members of the 
DNA checkpoint proteins germ cell quantifications at 1dpp. **-significant 
difference. Genetic background of C3Heb/FejA of at least 5 generations. 
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Table 3-2 FancmC4/C4 is lethal with Atm-/- 
  FancmC4/C4:Atm+/+ FancmC4/C4:Atm+/- FancmC4/C4:Atm-/- 
Observed 21 28 0 
Expected 12.25 24.5 12.25 
χ2 p-value 7.49E-05   
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  To find out what type of DNA damage is occurring that leads to apoptosis, 
we created double mutants that are involved in the double-strand break (DSB) 
repair pathway.  First cross involves Chk2, which phosphorylates a number of 
proteins for activation in the DSB response including TRP53. In these double 
mutants the germ cell loss was rescued (p=0.03, Figure 3-6E).  Upstream of 
CHK2 is Atm, which is activated by DSBs and phosphorylates CHK2 for 
activation.  Mice doubly mutant for FancmC4/C4 and Atm-/- are synthetic lethal 
(Table 3-2), however FancmC4/C4;Atm+/- mice exhibit a partial rescue of germ cell 
loss (p=0.002 Figure 3-6D).  This suggests that some, if not all, of the germ cell 
loss that is occurring in FancmC4/C4 mice is due to DSBs that are unrepaired 
leading to apoptosis.  The synthetic lethality seen with Atm-/- is consistent with 
other mutants in the FA complex (31).  This indicates that FANCM functions in a 
parallel pathway, such as that activated by ATR, which mediates repair of 
damage that occurs during DNA replication.  
 
FancmC4/C4 and FancmXH/XH primary cell lines exhibit elevated chromosomal 
abnormalities. 
FA cells are known to have elevated DNA breaks and radial 
chromosomes.  This phenotype is exhibited in FancmC4/C4 and FancmXH/XH 
primary mouse embryonic fibroblasts (MEFs) (Figure 3-7B,C,E).  The 
FancmKO/KO cells also have an increase in sister chromatid exchange (SCE), 
which is the number of exchanges between sister chromatids in order for DNA 
repair to occur (16). In primary MEFs we observed an elevation in SCE in the 
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Figure 3-7 Elevated chromosomal instability and sister chromatid 
exchange.  A-E Metaphase spreads of primary MEFs of given genotype.  SCE 
assay performed on A,B,D,E,F with differential staining of the sister chromatids.  
When there is increased sister chromatid exchange occurring there is more of a 
step-ladder effect on the chromosome arms of alternating light/dark staining 
(orange arrows). G The differences are significant in FancmC4/C4 and FancmXH/XH 
MEFS by TTEST p<0.05.  B,E shows examples of radial formations seen in the 
Fancm mutant cells (red arrows). C The occasional break that is seen in the 
Fancm mutant cells (arrowhead). Wild-type (WT), FancmC4/C4 (C4/C4), 
FancmC4/XH (C4/XH), and FancmXH/XH (XH/XH). 
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FancMC4/C4  (TTEST p<0.001), and in the FancmXH/XH MEFs (TTEST p=0.01).  
However, an insufficient number of FancmC4/XH MEFs were analyzed to make a 
conclusion regarding possible elevation in SCE (Figure 3-7A,D,F). 
 
FancmC4/C4 deficient females are tumor susceptible 
Since the mutant animals have genomic instability in the form of 
micronuclei in peripheral blood, primary MEFs have elevated chromosomal 
abberations, and the FancmKO/KO animals had an elevated tumor rate (16), our 
mutant mice were aged up to 1.5yrs to assess possible tumor susceptibility.  
FancmC4/C4 and FancmC4/+females had an elevated susceptibility to tumors 
(Table 3-3 and 3-4).  Meanwhile in males only one genotype had an increase in 
tumor incidence, the 12-48wk old FancmC4/XH males, which had one case of 
lymphoma (28wks), a lung adenoma (45wks), and a hepatoma(45wks) (Tables 3-
3 and 3-4). The earliest tumor onset in wild-type occurred at 52wks (Tables 3-3 
and 3-4). 
 
Diminished cell growth, premature senescence, with no drug 
hypersensitivity observed in mutant cells. 
Upon analysis of primary MEFs, cell growth of all mutant lines were 
diminished from wild-type (Figure 3-8A). We analyzed population doubling and in 
all mutant MEFs premature senescence occurred (Figure 3-8C). The timing of 
immortalization of these lines occurred at different passages. FancmC4/C4 line  
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Table 3-3 Tumor Frequency of Fancm mutants. 
TUMOR Frequency-Females  
WT 0 out of 28 (44-80wks) 0.00% 
C4/+ 9 out of 27 (44-80wks) 33.33% 
C4/C4 15 out of 26 (44-80wks) 57.69% 
C4/XH 1 out of 6 (20-54wks) 16.67% 
XH/XH 0 out of 5 (28-52wks) 0.00% 
   
   
TUMOR Frequency-Males  
WT and HETs 19 out of 36 (50-80wks) 55.26% 
C4/C4 8 out of 17 (70-80wks) 47.06% 
C4/XH 3 out of 12 (12-48wks) 25.00% 
XH/XH 0 out of 8 (12-78wks) 0.00% 
WT 4 out of 45 (12-55 wks) 9.00% 
   
Wild-type (WT), FancmC4/C4 (C4/C4), FancmC4/XH (C4/XH), and FancmXH/XH (XH/XH) mutant 
alleles 
 
Table 3-4 Histopathology of Fancm mutant mice 
Animal Age (wks) Genotype   Histopathology Tumor 
17251 54 WT Female 
Ovary - follicular cyst; spleen - red pulp mildly expanded 
by extramedullary heperplasia (EMH) and abundant 
hemosiderin laden macrophages, white pulp also mildly 
hyperplastic; uterus - mild cystic endometrial hyperplasia 
and dilation of lumen 
 
13116 45 WT Female Follicular cyst  
11125 81 WT Female ovary - 2 small follicular cysts  
16096 80 WT Female Follicular cyst and hemorrhagic cyst   
2611 106 Chaos4/+ Female Epithelial Tumor X 
13894 81 chaos4/+ Female one fluid filled cyst on each ovary  
13896 81 chaos4/+ Female Follicular cysts  
21225 66 chaos4/+ Female Ovarian Teratoma X 
21226 66 chaos4/+ Female uterine edema, adrenal gland tumor?, small spleen, small black tumors on lung X 
404 46 Chaos4/+ Female uterus - some proteinaceous fluid and neuts in lumen  
11123 81 Chaos4/+ Female uterus - unilateral hydro/mucometra; cystic endometrial hyperplasia, potential adenomyosis  
13118 45 chaos4/+ Female ovary - multifocal mineralized follicles unilateral;  
14389 75 Chaos4/+ Female Liver Tumor X 
14391 75 Chaos4/+ Female 1 fluid cyst on each, fluid filled uterus, but not too enlarged, there ma have been a small mammary tumor.  
14652 83 Chaos4/+ Female Follicular cyst  
14964 81 Chaos4/+ Female Hemorrhagic ovarian cyst X 
15364 80 Chaos4/+ Female 
ovary - large follicular cyst; uterus - multifocal 
perivascular lymphoid aggregates; liver - multifocal 
perivascular lymphoid aggregates; cervical lymph node - 
paracortex expanded by sheets of lymphocytes, small cell 
lymphoma 
X 
15868 50 Chaos4/+ Female 
ovary - unilateral follicular cyst; uterus - abundant 
nondegenerate neutrophils in glands, endometrium, 
lumen; liver - mild multifocal emh 
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16095 80 chaos4/+ Female liver - hepatocellular carcinoma and hematoma;  X 
#154 102 Chaos4/+ Female 
adrenal - mild subcapsular cell hyperplasia;liver - mild 
multifocal EMH and necrotizing hepatitis; mammary gland 
- mild lymphoid infiltrates; spleen - moderate hemosiderin 
in white and red pulp 
 
11108 95 Chaos4/+ Female Ovary - tubulostroma hyperplasia; liver - large biliary cyst with peripheral inflammatory infiltrates  
11110 95 Chaos4/+ Female 
Liver, spleen - histiocytic sarcoma; kidney - mineral in 
distal collecting ducts, mild multifocal tubular ectasia and 
proteinosis; adrenal gland - locally extensive moderate 
subscapsular cell hyperplasia; ovary and uterus - some 
neoplastic cells in peripheral adipose;brain - multifocal 
mineralized blood vessels in brainstem and thalamus 
X 
11118 81 Chaos4/+ Female ovary - paraovarian cyst; mineralized follicles; mammary gland adenocarcinoma X 
11119 81 Chaos4/+ Female ovary - follicular cyst;   
17247 54 XH297/+ Female Uterus - mild hydrometra   
2708 58 Chaos4/Chaos4 Female Basisquamous carcinoma X 
17817 24 chaos4/chaos4 Female Uterine Tumor X 
21223 66 chaos4/chaos4 Female cystic ovary, edema, start of a liver tumor, cyst on kidney, brown hair stripes, intestinal tumors, small lump on tail X 
402 46 Chaos4/Chaos4 Female 
endometrial hyperplasia-adenoma based on size(UT), 
Ov-cavernous sinuses that may have lead to the corpora 
hemorrhagia 
X 
3368 85 Chaos4/Chaos4 female Mammary or epithelial tumor X 
11124 81 Chaos4/Chaos4 Female ovary - multiple cysts compressing and distorting ovarian architecture, Liver and Lung adenoma X 
13117 45 chaos4/chaos4 Female Skin Tumor, hemorrhagic ovarian cyst X 
14390 75 Chaos4/Chaos4 female Uterine Tumor, skin tumor, follicular cysts X 
14650 83 Chaos4/Chaos4 Female Mammary Tumor X 
14965 81 Chaos4/Chaos4 Female Mammary Tumor, follicular cysts X 
14967 81 Chaos4/Chaos4 Female Liver Tumor X 
16097 80 chaos4/chaos4 Female Uterine Tumor, follicular cysts X 
19169 24 chaos4/chaos4 Female Follicular cyst  
#155 102 Chaos4/Chaos4 Female Brain and epithelial tumors X 
11113 99 Chaos4/Chaos4 Female Multiple small liver tumors, mammary tumor X 
11116 81 Chaos4/Chaos4 Female 
caverous hemoraghioma cysts, and paraovarium cyst in 
second ovary. Tumor-secratory mammary 
adenocarcinoma 
X 
11117 81 Chaos4/Chaos4 Female 
 tubularstromal adenoma/carcinoma low grade, bloody 
cystic oavary- another  potentian tubular stromal 
carcinoma, UT-polypoid adenoma, endometric 
hypersplasia, Lung- 2 early adenomas 
X 
17248 54 Chaos4/XH297 Female Spleen - mild lymphoid hyperplasia; ovary - large (9 mm) follicular cyst with mineralization  
20397 31 Chaos4/XH297 Female Spleen - mild lymphoid hyperplasia  
20692 26 Chaos4/XH297 Female 
Uterus - some hemosiderin laden macrophages in wall; 
spleen - mild lymphoid hyperplasia, many hemosiderin 
laden macrophages in white pul 
 
20761 21 Chaos4/XH297 Female Spleen - lymphoid hyperplasia, mild increase in EMH  
21003 21 Chaos4/XH297 female Bone tumor on Jaw 7X11mm X 
            
16802 52 WT Male Liver Adenoma X 
17877 55 WT Male Islet cell tumor X 
13115 85 WT Male Liver Tumor X 
13113 85 WT Male Liver Tumor X 
13889 72 chaos4/+ Male Liver Tumor X 
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14199 80 chaos4/+ Male Liver Tumors X 
11307 89 Chaos4/+ Male liver - focal adenoma X 
11311 89 chaos4/+ Male 
preputial gland - keratin filled cyst, focal suppurative and 
granulomatous inflammation; liver - multifocal areas of 
mineralization surrounded by fibrous connective tissue 
 
14388 69 Chaos4/+ Male Liver Tumors X 
14648 83 Chaos4/+ Male liver - hepatocellular carcinoma and hematoma X 
14960 81 Chaos4/+ Male liver - hepatocellular carcinoma X 
14646 83 chaos4/+ Male liver - hepatocellular carcinoma X 
14200 80 chaos4/chaos4 Male Lung Tumor X 
11310 89 chaos4/chaos4 Male liver - hepatocellular carcinoma;   X 
13984 80 chaos4/chaos4 Male kidney - mild multifocal tubular mineralization; liver - multiple adenomas X 
13985 80 chaos4/chaos4 Male lung - multifocal peribronchiolar and perivascular lymphoid aggregates  
14647 83 Chaos4/Chaos4 Male liver - hepatocellular carcinoma X 
15359 80 Chaos4/Chaos4 Male testis - mineralized and sclerotic  
16092 80 chaos4/chaos4 Male 
haired skin - focal pyogranulomatous inflammation and 
sebaceous gland hyperplasia (is this near the ear?; lymph 
nodes, moderately reactive; liver - adenoma and focus of 
cellular alteration 
X 
16094 73 Chaos4/Chaos4 Male 
Testis - rare multinucleate cells, <10% of tubules lined by 
single layer vacuolated Sertoli cells; Spleen - marked 
myeloid hyperplasia and splenomegaly; haired skin - 
infundibular keratinizing acanthoma; locally extensive 
hepatic necrosis; peritonitis and pancreatitis;  
 
11104 106 Chaos4/Chaos4 Male Liver - hepatocellular carcinoma; testis - focal hemangioma with fibrin thrombin, mild degeneration X 
11105 106 Chaos4/Chaos4 Male 
Testis - severe degeneration, most tubules lined by single 
layer of vacuolated sertoli cells, focal cavernous 
hemangioma 
  
20345 34 Chaos4/XH297 Male expanded T cell areas in spleen, lymph nodes, thymus  
20346 34 Chaos4/XH297 Male spleen - mild lymphoid hyperplasia  
20389 29 Chaos4/XH297 Male Lymph nodes, thymus - lymphoma X 
20393 31 Chaos4/XH297 Male Subcutis - follicular cyst; lymphoid hyperplasia in spleen  
20689 30 Chaos4/XH297 Male Spleen - red pulp mildy expanded by extramedullary hyperplasia(EMH)  
20690 26 Chaos4/XH297 Male liver - multifocal telangiectasia; lymph node - mild expansion of paracortex  
20691 26 Chaos4/XH297 Male spleen - mild expansion of red pulp (EMH) and white pulp (lymphoid hyperplasia)  
20998 45 Chaos4/XH297 Male Lung - adenoma; lymph nodes - many hemosiderin laden macrophages in sinuses X 
20999 45 Chaos4/XH297 Male Liver - adenoma X 
21001 48 Chaos4/XH297 Male lymph nodes - increased hemosiderin laden macrophages in one node   
20329 33 XH297/XH297 Male 
Liver - centrilobular hepatocytes large and vacuolated, 
multiple foci of necrotizing hepatitis; spleen - lymphoid 
hyperplasia and increased EMH 
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went through crisis and overcame senescence by passage 6.  The FancMC4/XH 
crisis occurred between passage 8 and 9, and the FancmXH/XH crisis was after 
passage 10 along with WT lines (Figure 3-8C).  All lines eventually did go on to 
become immortalized (not shown). With decreased cell growth and premature 
senescense we went on to observe the cell cycle through FACS analysis.  In 
both the FancmXH/XH and FancmC4/XH cells there was a G2/M delay/arrest, but this 
was not observed in the FancmC4/C4 cells (Figure 3-8B).  This difference in 
immortalization pattern may show the different types of genomic instability that is 
occurring and how the cell is may be able compensate.  
Since a characteristic of Fanconi anemia cells is sensitivity to crosslinking 
agents (MMC) and FANCM loss also leads to sensitivities to aphidicolin (APH) 
and camptothecin (CPT) (16), we tested whether our mutant alleles are also 
susceptible to these agents, which would be expected if relevant biochemical 
functions of the protein are defective.  In cells treated with MMC and APH there 
was no hypersensitivity, however there appears to be a slight resistance to CPT 
by FancmXH/XH MEFs in the lower drug concentrations (Figure 3-8D-F).  This 
suggests that these alleles of Fancm have retained some function for drug 
resistance even with the increase in genome instability, and that these alleles are 
not complete nulls. 
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Figure 3-8 Cell cycle defects and premature senescence in Fancm mutant 
cells, but no sensitivity to crosslinking agents or the replication inhibitor 
Aphidicolin.  
A Cell growth curves show a decrease in growth of the mutant cell lines in early 
passage primary MEFs. B  Cell cycle of MEFs at day 8 reveal a significant G2/M 
delay/arrest of FancmXH/XH and FancmC4/XH cell lines.  C  Population doubling in 
serial passaging reveals premature senescence in mutant cells with early crisis 
and recovery in FancmC4/C4.  D-F  Drug treatments of compounds and indicated 
concentration on X-axis with remaining cells measured on the Y-axis. Wild-type 
(WT), FancmC4/C4 (C4/C4), FancmC4/XH (C4/XH), and FancmXH/XH (XH/XH) mutant 
alleles. 
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3.4 Discussion 
 In this study I have described two mouse alleles of Fancm.  These mice 
have shown similarities and differences to the published knock-out mouse (Table 
3-5) (16).  The point mutation in the FancmC4 allele may affect the translocase 
activity, the ATPase activity or both.  However it may also affect the folding of the 
protein causing it to have reduced functional activity.  Based on the differences of 
phenotype from the null allele, this protein is hypomorphic and may retain the 
function of its endonuclease domain as well as most of its binding capabilities.  
The truncation protein that is presumed to form in the genetrap allele FancmXH 
may have retained its translocase and ATPase activity.  FancmXH may have also 
retained its ability to bind and anchor the FA proteins and localize to the 
chromatin. 
FANCM has multiple roles in DNA repair processes, from sensing DNA 
damage to choice and recruitment of repair pathways to facilitating repair. The N-
terminal helicase/translocase domain functions in DNA remodeling abilities, such 
as fork reversal, D-loop dissociation, and Holliday junction resolution. The N-
terminal of FANCM also has roles in moving the protein along chromatin to points 
of DNA damage and stalled forks.  The helicase/translocase domain interacts 
with FA proteins and is partially needed for FANCD2 mono-ubiquitination, 
however the ATPase activity is not required.  This domain is required for 
resistance to cross-linking agents and UV, but a point mutation that ablates the 
ATPase activity in DT40 cells but maintains the translocase activity is not 
sensitive to cross-linking agents (32).  This domain is required for suppression of 
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SCE and is needed for activation of the S-phase checkpoint (33).  A subset of 
these functions may be defective in the FancmC4/C4 mutant mouse. 
 The FancmXH/XH genetrap mouse putatively has a truncated FANCM 
protein causing a loss of the BLM interacting motif and the endonuclease 
domain.  The endonuclease domain is needed for interaction with FAAP24. Loss 
of the FANCM C-terminal domain shares some phenotypes with those of cells 
deficient for FAAP24 (3, 6–8, 27).  These include decreased ability to mono-
ubiquitinate FANCD2, decreased interaction with FA core complex, and decrease 
DNA substrate specificity.  This domain is partially required for resistance against 
crosslinking agents, however it is not required for resistance to UV.  The C-
terminal domain is however required for resistance to CPT (32, 34).  This domain 
is only partially required for suppression of SCEs.  In the S-phase checkpoint the 
C-terminal domain is required, possibly through its ability to stabilize RPA and 
through its interaction with HCLK (6-7). 
The decreased body size of FancmXH/XH mice may be caused by the DNA 
damage-induced apoptosis at the whole animal level.  Decreased body size is 
seen in other FA mouse mutants and in Atm mutants, but was not reported not in 
the FancmKO (16). The FancmXH/XH mutation is presumably a truncating mutation 
that leaves some function of FANCM N-terminal domains active, this leaves the 
possibility that the s-phase checkpoint is intact and allowing removal of damage 
cells, leading to a smaller body size. 
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Table 3-5 List of observed phenotypes in Fancm mutant mice  
  
Phenotype FancMKO/KO FancMC4/C4 FancMC4/XH FancMXH/XH 
Female Loss YES NO NO YES 
Decreased Body 
Size 
?? NO NO YES 
Germ Cell Loss YES YES NO? NO? 
Tumors YES YES MAYBE   NO? 
Chromosomal 
Abnormalities 
YES YES ?? YES 
Increased SCE YES YES NO? MAYBE 
MMC sensitivity YES NO? NO? NO? 
Cisplatin Sensitivity YES ?? ?? ?? 
CPT Sensitivity ?? NO? NO? Resistance? 
APH Sensitivity ?? NO NO NO 
G2/M Arrest YES? NO YES YES 
Early Senescence ?? YES YES YES 
FANCD2 mono-ub Decreased ?? ?? ?? 
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 FancmC4/C4 mice exhibit germ cell depletion, as do FancmKO mice and 
other mouse models of Fanconi Anemia.  This is very interesting since this allele 
is the one that has a mutation in the helicase domain that may interfere with one 
or all three activities associated with it; the translocase/helicase DNA remodeling 
function, the ATPase activity, or the interaction with HCLK, which is involved in 
stabilizing ATR and signals the s-phase checkpoint.  Without these, the ability to 
repair damage, this could lead to a loss of germ cells, typically through a p53 
dependant pathway.  The loss of germ cells in the FancmC4/C4 mice appears to 
be driven by this pathway, based on double mutant studies that showed a rescue 
of germ cells loss when in combination with Chk2-/-, Trp53-/-, or Cdkn1a-/-.  If 
signaling through the ATR pathway is compromised, such as the case may be in 
our mutants, than DNA lesions that occur during DNA replication may convert 
into DSBs.  This then activates the ATM pathway to trigger eventual repaired. 
The double mutant of FancmC4/C4 and Atm-/- is synthetic lethally showing that 
FANCM and ATM work in parallel pathways in DNA repair (28, 35, 36).   
The giant multinucleated cells seen in mice with these alleles of Fancm 
indicates DNA damage leading to incomplete mitosis and/or failed cytokenesis. 
Giant multinucleated cells are also seen in mice with reduced levels of TRP53, 
which implies that an alternative method of removing damaged cells may be 
invoked by both Fancm and Trp53 mutants (28, 35, 36).  This phenotype is not 
as obvious in the FancmXH/XH testes, which may be due to the fact that the repair 
mechanism is more functional in this mutant or that an alternative repair is still 
functional.  
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The meiotic defects in FancmC4/C4 leads to persistent RAD51 and γH2AX 
in meiotic spreads.  As animals age an almost total meiotic-like arrest is 
observed within the seminiferous tubules as the damage continues to 
accumulate.  Meiotic defects such as unrepaired DNA damage and mispaired 
chromosomes have been observed in a number of FA mutants (37, 38). 
Both FancmC4/C4 and FancmXH/XH cells have increased SCE rates, but how 
the SCEs are forming may be related to 2 different mechanisms.  In FancmC4/C4 
cells, SCEs may be forming due to lack of activity of the helicase/translocase 
during fork-reversal and D-loop disruption, leading to an increase in DSBs that 
need to get repaired leading to the activation of SCE.  In FancmXH/XH, the allele 
lacks the C-terminus, including the MM2 motif which interacts with RMI1 and 
TOPOIIIα and acts as a landing pad for BLM (20, 39).  If there is a lack of BLM 
this will result in a loss of HR, the cells then choose to use SCE to repair the 
damage. This phenotype is seen in BLM mutant cells (39). 
The unperturbed G2/M delay/arrest noted in FancmC4/XH and FancmXH/XH 
but not the FancmC4/C4 cells indicates that, while DNA damage is occurring in 
these mutants of Fancm, only FancmC4/C4 cells seem to be able to go through 
both the S-phase checkpoint as well as the mitotic checkpoint without causing 
any noticeable cell cycle delays.  This may be that the amount of DNA damage 
that has occurred in these cells may be less or that the types of lesions 
remaining are different. This may indicated the repair function in the FancmC4/C4 
is able to function better, or there is a lack of checkpoint signaling. 
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Taken together this repertoire of Fancm mouse alleles will allow for further 
dissection of the roles of FANCM within the S-phase checkpoint, its repair 
functions within the Fanconi Anemia complementation group, as well as the DNA 
damage sensing and repair abilities outside of the FA complex. 
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3.5 Methods 
Mice.  ENU mutagenesis of mice was performed as previously described (29).  
Micronuclei assay was performed as previously described (29). Genetic mapping 
using micronuclei as the phenotype was done as previously described (40).  
Sequencing of candidate genes was done by using cDNA derived from mutant 
animal testis RNA using gene specific primers the genes were amplified and then 
Sanger sequenced.  Gene trap-bearing ES cell lines (from 129 substrains) ware 
obtained from BayGenomics (XH297). Chimeras were generated by 
microinjection of the ES cells into C57BL/6J blastocysts using standard 
procedures.  Following germ-line transmission, alleles were backcrossed into 
C3HeB/FeJa (“C3H”). Exact insertion sites of gene trap vectors were determined 
by “primer walking” as described (29).  Genotyping of these animals were 
performed either by PCR amplification of the neo gene within the vector, by 
insertion-specific assay, or utilizing polymorphic flanking microsatellite markers 
D12Mit69, D12Mit71 that are polymorphic between 129 and C3H and B6. 
 
Histology and immunohistochemistry.  For basic histology, tissues were fixed 
in 4% paraformaldehyde overnight, paraffin embedded, sectioned, and stained 
with hematoxylin and eosin (H&E).  For germ cell counts, 10µM sections of 1 day 
old gonads were immunostained as described (41, 42). Antibodies: Rabbit anti-
DDX4/MVH (Abcam ab13840, 1:250); goat anti-rabbit Alexa 488 conjugate 
(Molecular Probes A11008, 1:1000).  Germ cells were counted in three sections 
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one-way ANOVA with Bonferroni correction (Prism software package).  The 
resulting P values were used to determine significance (P<0.05). 
 
MEF growth studies.  MEF growth analyses and metaphase spreads were 
performed as described (43).  For senescence assays, cells were counted every 
3 days and replated at 5X105 and passaged until they became immortalized. 
 Drug treatments were performed for 2 hrs at concentrations noted, the drugs 
were removed and cells were placed in normal with counts of surviving cells after 
48 hrs.  Sister-chromatid exchange assay were performed as previously 
described (16).  
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Chapter 4:  Meeting at the Fork, MCM9 and FANCM. 
 
The MCM2-7 DNA replicative helicase paralog, MCM9, is not essential for 
DNA replication (1).  This is contrary to the in vitro data from Xenopus extracts 
where loss of MCM9 results in loss of DNA replication (2).  As described in 
Chapter 2, mice lacking MCM9 display germ cell depletion, loss of 
spermatogonial stem cells as males age, and increased tumor formation.  MCM9 
mutant MEFs undergo premature senescence, exhibit increased chromatid 
breaks, and have a delayed release into S-phase following aphidicolin (APH) 
treatment. The pleotropic phenotypes in Mcm9 mutants share commonalities with 
mice ablated for Fanconi anemia (FA) genes, which raises the intriguing 
possibility that MCM9 may function in concert with the FA complementation 
group during DNA replication.   
The FA complementation group is involved in stabilizing collapsed and/or 
arrested replication forks, appears to work in concert with translesion synthesis 
and homologous recombination proteins to repair damage during DNA 
replication, and promotes ATR-mediated checkpoint signaling (3–11).  All of the 
FA complementation group members that have been mutated in mice result in 
subfertility and germ cell depletion, and some FA mouse mutants also show 
cancer susceptibility at relatively older ages (12).  
The other mouse mutants I have described in Chapter 3, are members of 
the Fanconi Anemia complementation group, containing separation of function 
mutations in Fancm.  The Fancm mutants exhibit genomic instability, but lack 
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hypersensitivity to DNA damaging agents, and only one mutant allele exhibits 
germ cell depletion. Since both the MCM2-7 DNA replicative helicase and the 
Fanconi Anemia complementation group function at the DNA replication fork, I’ll 
speculate about the precise role MCM9 in DNA replication and/or DNA repair and 
how it may interact with the Fanconi Anemia proteins. 
 
4.1 Origin specification. 
In order for DNA replication to occur, origins of replication need to be 
specified.  First the origin is bound by the origin recognition complex (ORC), 
followed by binding of CDC6 and CDT1 which then proceeds to load the  
MCM2-7 heterohexameric helicase.  This collection of proteins composes the 
pre-replication complex (pre-RC), and the origin is now “licensed” (Figure 4-1) 
(13). In order to become active, CDC7 and CDK remove CDC6 and recruit 
MCM10.  MCM10 with MCM2-7 recruits CDC45, followed by the rest of the 
replisome (13). There are two other MCM paralogs, MCM8 and MCM9, which 
have not yet been shown to interact with MCM2-7.  These two genes have arisen 
or were lost together during evolution (14), and both have been shown to interact 
with different pre-RC factors.  MCM8 physically interacts with CDC6 (15), and 
MCM9 was shown to interact with CDT1 (2).  What are their roles, if any, in pre-
RC function and do they function together or independently?  
MCM9 does not appear to be involved in origin loading, as indicated by 
the equal amounts of loaded MCM2-7 and CDT1 in MCM9 mutant cells when  
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Figure 4-1 Origin Specification 
A. During G1 phase of the cell cycle, a number of origins of replication are 
licensed with the factors needed to initiate DNA replication.  At the start of S-
phase only a subset of these origins are activated. Does MCM9 have a role in 
determining the active origin? B. As the DNA replication fork elongates it may 
encounter DNA lesions (red star),that may inhibit the fork from progressing.  Is 
MCM9 involved in activating dormant origins during replication stress? C.  If the 
replication fork progresses normally the other dormant origins need to be 
removed so replication can proceed past them.  Is MCM9 involved in removal of 
proteins from dormant origins? 
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compared to wild-type (1). We have also shown that a decrease in the number of 
active origins, through the Mcm4Chaos3/Chaos3:Mcm2GT/+ males (16), does not lead 
to germ cell loss (1).  However, this does not exclude a role for MCM9 at the 
DNA replication origin. MCM9 may have a role in selecting the active origin 
(Figure 4-1A). Cells lacking MCM9 may show a change in the commonly 
activated origins, or have a difference in intra-origin distances.  If MCM9 is 
involved in offloading of dormant origins then there should be a delay in S-phase 
progression as the active replication machinery attempts to proceed (Figure 4-1). 
There are more origins licensed than what become active origins of 
replication (17–20).  The remaining “dormant” origins are there as back-up in 
case an active origin is no longer able to proceed (Figure 4-1).  One theory on 
origin selection and activation of dormant origins involves origin “factories”, 
where replication factors act locally to select one active origin within a certain 
chromatin domain.  When a replication fork is compromised, the DNA damage 
checkpoint protein CHK1 prevents distant late origins from firing while nearby 
dormant origins fire within the origin factory.  However, the mechanism that 
regulates specific origin firing is not clearly understood (21–23). What is the 
determining factor that decides which pre-RC gets activated?  How do origins 
remain dormant until a fork is stressed?  How is a dormant origin removed when 
the replication fork needs to proceed?  
 
 
 
109"
4.2 Replication Stress 
MCM9 may be involved in activating dormant origins at times of replication 
stress (Figure 4-1B). Aphidicolin (APH) is a DNA polymerase inhibitor causing 
ssDNA to accumulate and become bound by RPA, which acts as a signal for S-
phase checkpoints activation and halting of replication.  It has been shown that 
ATR and ATM are not responsible for the APH-induced origin refiring, suggesting 
that another factor signals when replication is ready to proceed (24).  When cells 
are released from APH there is a staggered delay of origin re-start and new 
origin firing (24). What signals this firing?  In Mcm9 mutant MEFs, we see a delay 
of restart from APH block into S-phase.  Is this due to lack of signal of which 
origins should be fired?  Is this due to lack of restart of stalled replication forks?  
Delayed choice of dormant origin to be activated? 
 
4.3 ICL, MCM9, and similarity to Fanconi Anemia 
DNA breaks, DNA adducts, and DNA interstrand crosslinks at the 
replication fork interfere with its progression.  When the replisome encounters 
lesions, such as DNA breaks and DNA adducts, DNA synthesis is unable to 
continue.  This leaves long stretches of ssDNA onto which RPA binds (Figure 4-
2A).  RPA then allows the ATR-Chk1 signaling pathway to be activated which 
stops the MCM2-7 helicase from progressing and dormant origins are prevented 
from firing until needed (25). However, when the MCM2-7 DNA helicase 
encounters an interstrand crosslink, the replisome is still able to progress to the 
point where MCM2-7 has stalled (Figure 4-2B).  This leaves no long stretch of 
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Figure 4-2  Replication Stress. 
A.  During DNA replication, DNA lesions such as DNA breaks and bulky 
lesions may cause the replisome to stop synthesizing DNA while the helicase 
continues on leaving long stretches of ssDNA.  This ssDNA is coated by RPA 
which signals through the ATR pathway to the MCM2-7 helicase to stop 
progressing.  Is MCM9 involved in this step to stop DNA replication during 
stress?  B.  If the MCM2-7 helicase encounters an interstrand crosslink there is 
no long stretch of ssDNA since the replisome is able to keep up with the DNA 
helicase.  C.  How is the ssDNA formed, is MCM9 responsible for unwinding the 
newly synthesized DNA to allow RPA to bind and signal the repair factors? 
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ssDNA for RPA to bind to facilitate DNA damage repair signaling.  The MCM2-7 
helicase has been shown to have a role in RPA loading and CHK1 
phosphorylation to signal repair when the fork encounters a lesion (26).  What 
causes ssDNA for RPA to bind when the MCM2-7 helicase encounters an 
interstrand crosslink?  Is it possible that MCM9 is involved in these functions 
(Figure 4-2)?   
As MCM2-7 elongates DNA for replication, MCM9 may travel with the 
elongating replication fork.  MCM9 may signal when the fork stops progressing 
and allow accumulation of RPA, either by inhibiting the polymerase, or by 
unwinding the newly formed DNA that is behind the fork to allow for RPA 
accumulation (Figure 4-2B,C). MCM9 may be involved in signaling when the fork 
has stopped progressing, and if this is true, there should be alteration of ATR-
Chk1 signaling. 
Recent studies reported that unreplicated regions flanked by two stalled 
forks that persist into M-phase are marked with sister foci of FANCD2, a Fanconi 
Anemia protein that presumably directs the resolution of such structures through 
homologous recombination (27). These FANCD2 foci have also been shown to 
form on the incompletely replication regions in Mcm4Chaos3 cells (28).  In these 
cells, there was also persistence of RAD51 and BLM foci.  
The connection between the DNA replicative helicase and the Fanconi 
Anemia pathway needs to be explored, as these protein families both function at 
the DNA replication fork.  MCM9 may be working as part of a sensor that travels 
with the MCM2-7 helicase and may signal a repair pathway when the fork has 
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stopped progressing at an interstrand crosslink (Figure 4-2&3).  MCM9 may be 
involved in the restart of the replication fork after the repair is complete at the 
stalled fork (Figure 4-3), either as the DNA helicase or by reloading, recruiting, or 
activating MCM2-7.  If the damage has been repaired, but the fork has failed to 
restart, this could lead to unreplicated DNA or slowed DNA replication. 
FANCM has been show through multiple biochemical assays to be involved in 
many stages of DNA repair, from sensing damage, to activating S-phase 
checkpoint, to repair pathway choice, and actually facilitating repair by 
remodeling the replication fork (29). FANCM loss enhances sensitivity to the 
DNA damaging agents UV (activates nucleotide excision repair) and 
camptothecin (CPT, activates double stranded break repair) in addition to MMC.  
FANCM may have a role in sensing or bringing in repair factors for these different 
types of DNA lesions that interfere with the progression of the DNA replication 
fork. Loss of FANCM allows the replication fork to proceed at a faster rate (30). In 
addition, FANCM loss causes RPA to be destabilized on ssDNA (10) (Figure 4-
3). FANCM also has the ability to remodel DNA replication forks into chicken foot 
structures for fork reversal, to resolve Holliday Junctions, and is involved in D-
loop formation (31–36).  FANCM also has the ability to activate ATR checkpoint 
signaling, stabilize RPA formation, and tether FA and BLM for repair (9, 10, 30, 
37–41).  All of this data suggests that FANCM travels with the DNA replication 
fork and has multiple roles in DNA repair at the DNA replication fork. 
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Figure 4-3 The role of FANCM at the replication fork. 
A. FANCM may travel along with the DNA replication machinery and act 
as a sensor for DNA damage.  When damage is encountered, FANCM signals to 
ATR which then stops the progression of the replication fork.  B.  FANCM then 
goes on to stabilize/load RPA onto ssDNA and then serve as an anchor for the 
Fanconi Anemia proteins and BLM for repair of some lesions.  C.  FANCM may 
help restart the fork through fork reversal and allow the DNA helicase, or MCM9, 
to reload.  D. DNA replication can proceed again. 
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4.4 Break-induced Replication 
Break-induced replication (BIR) is a homologous recombination repair 
pathway that acts when double-strand breaks only have one end that shares  
homology.  The end invades into the homologous region utilizing the RAD51 
filament and then instead of a short stretch of DNA synthesis, the replication 
machinery is engaged and replication proceeds to the end of the chromosome 
(42–44) (Figure 4-4).  This mechanism is used to restart forks when the 
replication machinery has become uncoupled.  BIR is also an alternative 
mechanism (ALT) of maintaining telomeres in the absence of telomerase (42, 45, 
46).  Telomerase itself is primarily active in the stem and germ cells and is turned 
off in somatic cells.  Telomerase null mice exhibit anemia, bone marrow failure, 
and defects in the gastrointestinal tract and skin, in addition to germ cell loss due 
to apoptosis (47).  
The replication machinery was shown to be engaged during BIR in 
budding yeast (42), which lacks MCM8 and MCM9.  In eukaryotes that have 
MCM8/9, it is possible that these proteins are used to activate BIR and ALT 
(Figure 4-4).  MCM8 and/or MCM9 may be facilitating the repair by opening up 
the DNA so that the repair and replication machinery can access the template 
DNA.  MCM8 and/or MCM9 may be acting as a DNA repair helicase in this type 
of repair.   
Loss of telomere maintenance can lead to premature senescence. The 
early regulation of telomere length is decided by a telomerase-free system, either 
through Telomere-sister chromatid exchange or DNA recombination (48).  In this  
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Figure 4-4 Break-induced replication 
A. A dsDNA break has formed and the HR repair pathway begins a 
homology search.  B.  When homology is found strand invasion and DNA 
synthesis begins, does MCM9 facilitate the opening of the chromatin for DNA 
synthesis to occur?  C.  If there is homology found for only one end of the break, 
DNA replication will occur and proceed to the end of the chromosome.  
Alternative lengthening of telomeres also may take place.  Is MCM9 the DNA 
helicase for this mechanism, or is it involved with loading of the other replicative 
factors in the absence of an origin of replication?  D.  When replication is 
completed loss of heterozygosity results.  
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system the shorten telomeres seen in the zygotes are lengthen from the 1-cell 
stage through the blastocyst stage (48). Could BIR also have a role in this early 
telomere lengthening?  Could MCM9 help decide replication “age” by maintaining 
telomere length? Since loss of MCM9 causes premature senescence in primary 
MEFS, could this be due to premature shortening of telomeres? A premature 
senescence phenotype could also explain the shortfall of germ cells, as they 
might have stopped proliferating earlier.  This may explain the continued loss of 
the spermatogonial stem cell compartment as they terminally differentiate.  
If MCM9 is involved in the BIR pathway it may allow us a unique look at 
stem cells and how a replication-linked gene may affect its ability to replicate and 
divide.  This mechanism may control how many cycles of replication a stem cell 
goes through, and without MCM9 the cell could terminally differentiate. 
 
4.5 Germ cell loss and DNA repair.  
Accurate transmission of genetic information is critical to the health and 
the success of species.  Proper specification and maintenance of the germ-line 
stem cell is a key part of this. During gamete formation genome maintenance is 
critical to prevent mutation, insertions, and deletions to prevent the offspring from 
inheriting defects that may be detrimental. 
Of the 19 genes reported to cause “decreased primordial germ cell 
number” in the Mouse Genome Database, only Fancl, and Pin1 have known 
roles in genome maintenance.  The other FA genes also cause primordial germ 
cell depletion, but these haven’t been investigated fully and are not listed.  
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Numerous other DNA repair genes have been studied in mice, but none have 
been linked to primordial germ cell depletion.  Pin1 has been implicated in the 
control of cell cycle progression, telomere maintenance, and DNA damage and 
replication checkpoints.  In primordial germ cells Pin1 is required for the normal 
progression of the cell cycle in proliferation during and immediately after 
migration of the germ cells (49, 50).  Fancl is specifically required for the 
proliferation of post-migratory primordial germ cells but not the proliferation of 
migratory primordial germ cells (51).  Fancl is an E3 ligase and a member of the 
Fanconi anemia complementation group. 
The FA complementation group mutants are the only set of DNA repair 
genes that have exhibited primordial germ cell depletion.  This suggests that 
germ cells are hypersensitive to the loss of the ability to repair interstrand 
crosslinks.  Is it because these cells are more prone to ICL during gamete 
formation? Is it due to specific ICL that affect transcription of certain genes? It 
has been shown that during epigenetic reprogramming ssDNA is formed that 
may be resolved through the BER pathway (53).  Is FANCM important part of 
signaling in this pathway? Is it that these germ cells are undergoing rapid 
proliferation during gametogenesis that the FA repair pathway is the preferred 
mechanism for screening and repair of genomic damage? 
As shown earlier FANCM is involved in sensing or repairing numerous 
types of DNA damage that can be found during procession of the replication fork.  
Loss of FANCM results in a quicker procession of the replication fork (30),this 
suggests that FANCM may travel with the replication machinery. This leaves the 
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possibility that FANCM is a key part of the mechanism that maintains genomic 
integrity during the rapid proliferation and expansion of the germ cells. 
With the FANCM mutants, we have an opportunity to study separation of 
function in gametes with one hypomorphic allele, FancmC4/C4, that results in germ 
cell loss, and the FancmXH/XH and FancmC4/XH alleles, do not exhibit germ cell 
loss. This loss of germ cells in FancmC4/C4 suggests FANCM ATPase, 
translocase or possibly some other function associated within this translocase 
domain is key in maintaining germ cell genome stability. The N-terminal 
translocase domain functions in DNA remodeling abilities.  The N-terminal of 
FANCM also has roles in moving the protein along chromatin to points of DNA 
damage and stalled forks.  The translocase domain is required for resistance to 
cross-linking agents and UV (52). This domain is required for suppression of 
SCE and is needed for activation of the S-phase checkpoint (29).  
The N-terminal translocase/helicase domain functions in DNA remodeling.  
The loss of this domain has its own consequences, however, is not likely the 
cause of the germ cell depletion. Since the loss of the endonuclease domain 
(which has substrate specificity binding activity) does not affect germ cell 
formation, The activities of the N-terminal DNA remodeling activities of FANCM is 
an upstream function, suggesting these are not the cause of germ cell loss.  This 
leaves the ability of FANCM to travel along the DNA and sense and signal DNA 
damage as the most likely cause of germ cell depletion.   
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4.6 Significance 
MCM9 is paralogous to the MCM2-7 DNA replicative helicase subunits, 
yet it does not appear to have a role in unperturbed DNA replication.  MCM9 
mutants have defects of the germ-line stem cells and are susceptible to 
hepatocellular carcinoma.  These phenotypes are similar to those mice with 
mutations in the Fanconi anemia complementation group, which is involved in 
DNA interstrand crosslink repair at the DNA replication fork.  The other mouse 
mutants described here are members of the Fanconi Anemia complementation 
group, with separation of function mutations in Fancm.  The Fancm mutants 
exhibit genomic instability, however lack DNA damaging agent hypersensitivity, 
and only one allele has germ cell depletion.  With this collection of mouse 
mutants we have a unique opportunity to study DNA replication-link DNA repair 
pathways.  Additionally, we will be able to tease out mechanisms involved in 
maintaining the genomic integrity of germ-line stem cells. 
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